{"gene":"NFATC4","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1999,"finding":"NFATc4 (NF-ATc4/NF-AT3) in hippocampal neurons translocates from cytoplasm to nucleus and activates NF-AT-dependent transcription in response to electrical activity or potassium depolarization. This calcineurin-mediated nuclear translocation is critically dependent on calcium entry through L-type voltage-gated calcium channels. GSK-3 phosphorylates NFATc4, promoting its nuclear export and antagonizing NFATc4-dependent transcription.","method":"Neuronal activity/K+ depolarization assays, pharmacological inhibition of calcineurin and L-type Ca2+ channels, GSK-3 phosphorylation assays, reporter gene assays, nuclear translocation imaging","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (pharmacology, imaging, reporter assays, kinase assays) in a highly cited single study; findings replicated by multiple subsequent labs","pmids":["10537109"],"is_preprint":false},{"year":2002,"finding":"NFATc4 is phosphorylated by p38 MAP kinase at multiple residues including Ser168 and Ser170 within the NFAT homology domain. Replacement of Ser168,170 with Ala promotes nuclear localization of NFATc4 and increases NFAT-mediated transcription activity. NFATc4 is not phosphorylated by JNK. Constitutively nuclear NFATc4 (Ala168,170 mutant) promotes adipocyte differentiation via upregulation of PPARγ2, which is identified as a transcriptional target of NFAT.","method":"In vitro phosphorylation assays, site-directed mutagenesis, reporter assays, stable cell line expression, adipocyte differentiation assays, promoter analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, functional readout in cells, single lab with multiple orthogonal methods","pmids":["11997522"],"is_preprint":false},{"year":2001,"finding":"NFATc4 contains two transactivation domains at the NH2 and COOH termini, each interacting with distinct regions of the coactivator CBP (KIX and CH3 domains respectively). Both transactivation domains are required for CBP-mediated potentiation of NFATc4 transcription; removal of either domain abolishes CBP potentiation.","method":"Co-immunoprecipitation, deletion mutagenesis, reporter assays, in vitro binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple deletion mutants with functional validation, reciprocal binding assays, single lab","pmids":["11514544"],"is_preprint":false},{"year":2000,"finding":"In cardiac myocytes, Ras (but not Rac1, RhoA, or Cdc42) stimulates NFAT3 nuclear translocation and transcriptional activity via a calcineurin-dependent mechanism involving the MEK1/c-Raf/ERK2 pathway. Dominant-negative Ras blocks phenylephrine-stimulated NFAT3 activation and calcineurin activity. Cyclosporin A blocks V12ras-stimulated NFAT transcription, placing Ras upstream of calcineurin.","method":"Expression of constitutively active and dominant-negative Ras/GTPase mutants, reporter assays, NFAT3 nuclear localization imaging, calcineurin activity assays, pharmacological inhibitors","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — epistasis established by multiple genetic tools (dominant-negative, constitutively active), multiple readouts, single lab","pmids":["11044444"],"is_preprint":false},{"year":2000,"finding":"In cardiomyocytes stimulated by electrical pacing, calcineurin-mediated dephosphorylation of NFAT3 allows its translocation to the nucleus where it directly participates in activation of the Adss1 gene. Mutational analysis of the Adss1 5'-flanking region shows an NFAT binding site is essential for this activation.","method":"Electrical pacing of neonatal cardiomyocytes, calcineurin dephosphorylation assay, nuclear translocation assay, promoter mutational analysis, reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional promoter mutagenesis and translocation assay, single lab","pmids":["10636885"],"is_preprint":false},{"year":2002,"finding":"Genetic disruption of NFATc4 does not impair cardiac hypertrophic growth; in contrast, NFATc3 knockout significantly reduces calcineurin transgene-induced and pressure overload-induced cardiac hypertrophy. This genetic evidence shows NFATc4 is dispensable for calcineurin-mediated cardiac hypertrophy while NFATc3 is required.","method":"Targeted gene disruption (knockout mice), cardiac hypertrophy models (calcineurin transgene, pressure overload, angiotensin II), morphometric analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with multiple hypertrophic stimuli, replicated across timepoints","pmids":["12370307"],"is_preprint":false},{"year":2003,"finding":"NFATc3 and NFATc4 are required for cardiac development; double knockout mice show embryonic lethality with thin ventricles, reduced cardiomyocyte proliferation, and defective mitochondrial function including reduced complex II and IV respiratory chain activity. Cardiac-specific expression of constitutively active NFATc4 in double-knockout embryos rescues ventricular myocyte proliferation, mitochondrial ultrastructure, and complex II enzyme activity, demonstrating NFATc4 is sufficient to support these functions.","method":"Double knockout mice, cardiac-specific rescue with constitutively active NFATc4 transgene, electron microscopy, enzymatic activity assays, histology","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — definitive genetic rescue experiment with biochemical validation of mitochondrial function","pmids":["12750314"],"is_preprint":false},{"year":2004,"finding":"In hippocampal neurons, NFATc4 (NFAT3) accumulates in the nucleus under survival conditions (serum and high K+) and is exported under pro-apoptotic conditions. GSK3 inhibition by Li+ blocks NFATc4 nuclear export and promotes survival. RNA interference knockdown of NFAT3 induces apoptosis even under survival conditions, while constitutively active NFAT protects against apoptosis, demonstrating a pro-survival transcriptional function for NFAT3 in cerebellar granule neurons.","method":"Primary neuron culture, nuclear localization imaging, RNAi knockdown, Li+ pharmacology, apoptosis assays, constitutively active NFAT expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — RNAi loss-of-function and gain-of-function with defined apoptosis readout, multiple orthogonal approaches, single lab","pmids":["15537643"],"is_preprint":false},{"year":2005,"finding":"NFATc4 (NFAT3) interacts with both ERα and ERβ in vitro and in mammalian cells in a ligand-independent manner, binding specifically to the ERβ activation function-1 domain. Overexpression of NFAT3 enhances ERα and ERβ transcriptional activities and upregulates downstream estrogen-responsive genes (pS2, cathepsin D). NFAT3 increases ERα binding to estrogen-responsive elements and is recruited to estrogen-responsive promoters.","method":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal binding assays (yeast 2-hybrid + co-IP + pulldown) plus ChIP and functional reporter, multiple orthogonal methods, single lab","pmids":["16219765"],"is_preprint":false},{"year":2005,"finding":"RSK (p90 ribosomal S6 kinase) is recruited to the NFATc4-DNA transcription complex upon activation, demonstrated by DNA affinity isolation coupled with in-gel kinase assays. Bound RSK phosphorylates NFATc4 at Ser676, potentiating its DNA binding by increasing NFAT-DNA association. ERK MAP kinase interacts with NFATc4 at a distinct region from RSK.","method":"DNA affinity isolation, in-gel kinase assays, site-directed mutagenesis, phosphorylation assays, EMSA","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, DNA affinity isolation, functional readout, single lab with multiple methods","pmids":["15657420"],"is_preprint":false},{"year":2007,"finding":"RSK2 directly interacts with NFATc4 (binding its NLS1, Ser/Pro repeat, and polyproline domains), phosphorylates NFATc4 in vitro (Km=3.559 μM), and induces nuclear localization of NFATc4 upon A23187 stimulation. RSK2-mediated activation of NFATc4 enhances its target gene promoter activity and promotes C2C12 myoblast differentiation into multinucleated myotubes. siRNA against RSK2, ERK1/2, or NFATc4 each inhibits myotube differentiation.","method":"Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, nuclear localization imaging, reporter assays, C2C12 differentiation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with Km determination, direct binding demonstrated, functional rescue/knockdown, single lab","pmids":["17213202"],"is_preprint":false},{"year":2008,"finding":"mTOR phosphorylates Ser168,170 of endogenous NFATc4 (gate-keeping residues controlling subcellular distribution), acting as a basal kinase to maintain NFATc4 in the cytosol. ERK5 MAP kinase also mediates rephosphorylation of Ser168,170 for nuclear export, and phosphorylation by ERK5 primes subsequent phosphorylation by CK1α. Ablation of ERK5 in Erk5-/- cells shows defects in NFATc4 rephosphorylation and nucleocytoplasmic shuttling.","method":"Phospho-specific monoclonal antibody, kinetic phosphorylation analyses, Erk5 knockout cells, pharmacological inhibition, mutagenesis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — phospho-specific antibody, genetic knockout validation, multiple kinase identification, single lab","pmids":["18347059"],"is_preprint":false},{"year":2008,"finding":"NFATc4 protein stability and transcriptional activity are regulated by ubiquitination via Lys48-linked polyubiquitin chains, leading to decreased protein levels. GSK3β activation enhances NFATc4 ubiquitination and decreases its transactivation, while GSK3β inhibition has opposite effects. Ubiquitination and GSK3β-induced phosphorylation together repress NFATc4-dependent cardiac-specific gene expression.","method":"Ubiquitination assays, Western blot, GSK3β activation/inhibition, reporter assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional ubiquitination assay with pharmacological GSK3β manipulation, single lab, single paper","pmids":["19026640"],"is_preprint":false},{"year":2008,"finding":"NFATc4 deafferentation-induced nuclear translocation and activation in AVCN neurons during a critical period is abolished by the calcineurin inhibitor FK506 and the NFAT-specific inhibitor 11R-VIVIT. NFATc4 activation mediates expression of FasL in cochlear nucleus, and NFAT inhibition attenuates deafferentation-induced apoptosis of AVCN neurons.","method":"In vivo cochlea removal, calcineurin inhibitor treatment, NFAT-specific peptide inhibitor (11R-VIVIT), immunostaining, apoptosis assays, FasL expression analysis","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with specific inhibitors, mechanistic link to FasL, single lab","pmids":["18354019"],"is_preprint":false},{"year":2009,"finding":"NFATc4 (NFAT-3) directly occupies the GAP-43 promoter and acts as a transcriptional repressor of GAP-43 in neurons. Overexpression of NFAT-3 represses GAP-43 activation mediated by neurotrophin signaling. Endogenous NFAT-3 occupies the GAP-43 promoter in PC-12 cells, cultured neurons, and mouse brain as shown by ChIP. NFAT-3 is required to repress physiological GAP-43 expression in specific developmental windows in the mouse brain.","method":"ChIP assay, overexpression, reporter assays, cortical neuron culture, in vivo brain analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP confirms direct promoter occupancy in vitro and in vivo, functional gain-of-function, single lab with multiple orthogonal approaches","pmids":["19443652"],"is_preprint":false},{"year":2009,"finding":"NFATc4 (NFAT isoform c4) activation by NMDAR stimulation in cortical neurons promotes antiapoptotic transcription, in part by regulating BDNF promoter IV transcription. NFATc4 knockdown reduces BDNF expression and induces cortical neuron apoptosis, while BDNF rescues from NFATc4 inhibition-induced apoptosis, establishing an NMDAR-NFATc4-BDNF pro-survival pathway.","method":"RNAi knockdown of NFATc4, NMDAR pharmacology, reporter assays (BDNF promoter IV), BDNF rescue experiment, apoptosis assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown with specific BDNF rescue, reporter assay, pathway epistasis established, single lab","pmids":["19955386"],"is_preprint":false},{"year":2010,"finding":"Lipin 1 represses NFATc4 transcriptional activity through direct protein-protein interaction. Both catalytically active and inactive lipin 1 suppress NFATc4 transcriptional activity, with suppression potentially involving recruitment of histone deacetylases to target promoters. Lipin 1 is present at the promoters of NFATc4 transcriptional targets (TNFα, resistin, FABP4, PPARγ) in vivo.","method":"Co-immunoprecipitation, reporter assays, ChIP assay, lipin-1 knockout mice, siRNA knockdown in 3T3-L1 adipocytes","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct protein interaction confirmed by Co-IP, ChIP establishes promoter occupancy, loss-of-function in vivo and in vitro, single lab","pmids":["20385772"],"is_preprint":false},{"year":2010,"finding":"NFAT3 inhibits LCN2 (Lipocalin 2) gene expression and thereby reduces migration of ERα+ breast cancer cells. NFAT3 cooperates with ERα to inhibit migration but inhibits invasion independently. NFAT3 downregulation results in actin reorganization associated with increased migration and invasion.","method":"siRNA knockdown, invasion/migration assays, gene expression analysis, actin staining","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional loss-of-function with specific cellular phenotype and target gene identified, single lab, limited mechanistic depth","pmids":["20101218"],"is_preprint":false},{"year":2011,"finding":"FoxP1 physically interacts with Nfat3 (NFATc4) in cardiomyocytes; calcineurin activation induces FoxP1-Nfat3 complex formation visualized by bimolecular fluorescence complementation (BiFC). Amino acid substitutions at the predicted interaction interface inhibit complex formation. FoxP1 represses hypertrophy-associated genes (Myh7, Rcan1, Cx43, Anf, Bnp) and counteracts their activation by constitutively nuclear Nfat3. FoxP1 and Nfat3 co-occupy promoter regions of hypertrophy-associated genes in neonatal and adult heart tissue by ChIP.","method":"BiFC, co-immunoprecipitation, mutagenesis of interaction interface, reporter assays, ChIP, cardiomyocyte hypertrophy assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct interaction visualized by BiFC, ChIP in native tissue, interface mutagenesis, functional consequence established, single lab","pmids":["21606195"],"is_preprint":false},{"year":2012,"finding":"NFATc4 calcineurin-dependent activity is required selectively for survival of adult-born neurons in response to BDNF signaling in the mouse dentate gyrus. In NFATc4-/- mice, cyclosporin A injection and BDNF scavenger (TrkB-Fc) do not reduce adult-born neuron survival, whereas they do in wild-type mice. Absence of NFATc4 leads to selective defects in LTP and hippocampal-dependent spatial memory encoding.","method":"NFATc4 knockout mice, cyclosporin A injection, stereotaxic TrkB-Fc delivery, BrdU labeling/survival assays, LTP recording, spatial memory testing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic knockout with pharmacological epistasis, mechanistic link to BDNF signaling, multiple behavioral and electrophysiological readouts, single lab","pmids":["22586092"],"is_preprint":false},{"year":2012,"finding":"NFATc4 undergoes nuclear translocation only after prolonged (1-3 h) depolarization in neurons, in contrast to NFATc3 which translocates rapidly (~20 min). The serine-proline repeat region of NFATc4 is critical for determining the magnitude of NFATc4 nuclear localization. Knockdown of GSK3β significantly increases depolarization-induced NFATc4 nuclear localization. Inhibition of p38 or mTOR has no significant effect on NFATc4 nuclear import in neurons.","method":"NFATc3/NFATc4 chimera analysis, siRNA knockdown of GSK3β/p38/mTOR, live-cell imaging of nuclear translocation, phosphorylation assays in hippocampal and DRG neurons","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — chimeric protein domain mapping, genetic knockdown epistasis, multiple kinases tested, single lab with multiple orthogonal methods","pmids":["22977251"],"is_preprint":false},{"year":2013,"finding":"NFAT3 (NFATc4) directly regulates miR-140 transcription by binding to the regulatory sequence of miR-140 (rsmiR-140). NFAT3 activation increases rsmiR-140 activity, and mutagenesis of NFAT binding sites in rsmiR-140 abolishes this activation. TGF-β interferes with NFAT3 translocation and subsequently decreases miR-140 expression. NFAT3 and SMAD3 directly regulate miR-140 independently of WWP2.","method":"siRNA silencing, luciferase reporter assays with mutagenesis, ChIP assay, immunocytochemistry","journal":"Arthritis research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct binding, mutagenesis validates specific sites, multiple methods, single lab","pmids":["24257415"],"is_preprint":false},{"year":2014,"finding":"NFATc4 is a transcriptional regulator of GABAA receptor subunits (GABRA2 and GABRA4) in hippocampal progenitor cells, regulating their expression via binding to specific promoter responsive elements as confirmed by ChIP and luciferase assays. GABAA receptor signaling modulates hippocampal neurogenesis through NFATc4 activity via calcineurin/NFATc4 axis.","method":"Genome-wide high-throughput study, ChIP assay, luciferase assays, calcineurin inhibitor treatment, NFATc4 knockout mice, neurogenesis quantification, behavioral assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP confirms direct promoter binding, knockout mouse validation, multiple functional readouts, single lab","pmids":["24948817"],"is_preprint":false},{"year":2015,"finding":"NFAT3 directly binds to specific DNA sequences within the BACE1 promoter (confirmed by ChIP), increasing BACE1 promoter activity and transcription. Overexpression of NFAT3 increases BACE1 and Aβ production; disruption of NFAT3 decreases BACE1 gene transcription and protein expression.","method":"ChIP assay, reporter assays, overexpression, siRNA knockdown, Aβ measurement, transgenic APP/PS1 mice analysis","journal":"Neurochemical research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct promoter binding, gain- and loss-of-function validated, single lab","pmids":["25663301"],"is_preprint":false},{"year":2016,"finding":"CDK3 (cyclin-dependent kinase 3) directly interacts with NFATc4 (NFAT3) and phosphorylates it at serine 259 (Ser259), enhancing its transactivation and transcriptional activity. The Ser259 phosphorylation is critical for EGF-stimulated cell transformation; mutation of NFAT3 at Ser259 reduces colony formation and xenograft tumor growth.","method":"Mammalian two-hybrid assay, in vitro kinase assay, site-directed mutagenesis (S259A), reporter assays, soft-agar colony formation, xenograft mouse model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with site-specific mutagenesis, direct interaction assay, functional phenotype in vitro and in vivo, single lab","pmids":["27893713"],"is_preprint":false},{"year":2016,"finding":"NFATc4 interacts with myocardin to synergistically activate expression of the LTCC α1C (L-type Ca2+ channel α1C subunit) in cardiomyocytes. NFATc4 activates myocardin expression by binding to its promoter (confirmed by ChIP). Co-IP demonstrates direct NFATc4-myocardin interaction.","method":"Co-immunoprecipitation, ChIP assay, overexpression, siRNA knockdown, reporter assays, immunofluorescence, calcineurin inhibitor treatment","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP confirm interaction and promoter binding, single lab","pmids":["27155398"],"is_preprint":false},{"year":2016,"finding":"Neuritin elevates intracellular Ca2+ and increases Kv4.2 expression via the Ca2+/calcineurin/NFATc4 axis in cerebellar granule neurons. NFATc4 is recruited to the Kv4.2 gene promoter (confirmed by ChIP and luciferase reporter). Neuritin-induced nuclear accumulation of NFATc4 and consequent Kv4.2 expression/neuronal excitability changes are abrogated in Nfatc4-/- but not Nfatc2-/- mice.","method":"Nfatc4 knockout mice, calcineurin inhibitor, ChIP assay, luciferase reporter, Ca2+ imaging, AAV-mediated overexpression, patch-clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — knockout mouse specificity, ChIP confirms direct promoter binding, multiple orthogonal methods, single lab","pmids":["27307045"],"is_preprint":false},{"year":2017,"finding":"NFAT3 expression in T cells is regulated by TBX5; TBX5 binds to the NFAT3 promoter and its mutation diminishes NFAT3 promoter activity. NFAT3 in T cells suppresses IL-2 expression, while NFAT1 enhances it. The region of NFAT3 responsible for IL-2 promoter activity inhibition maps to the N-terminal transactivation domain, Ca2+-regulatory domain, and DNA-binding domain (identified by NFAT1/NFAT3 chimeric molecules).","method":"RNAi knockdown, reporter assays, NFAT1/NFAT3 chimeric molecules, promoter mutagenesis, TBX5 overexpression in T cells, chromatin accessibility analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chimeric domain mapping, mutagenesis, functional gain/loss-of-function, single lab","pmids":["29180489"],"is_preprint":false},{"year":2018,"finding":"BDNF regulates neurodevelopmental timing via sequestration of NFATc4 in Golgi (extranuclear compartment), preventing its transcriptional repressor activity. This leads to accelerated derepression of an NFI temporal occupancy gene program in cerebellar granule cells, including Bdnf itself, forming an autoregulatory loop.","method":"Subcellular fractionation/imaging of NFATc4-Golgi localization, NFI target gene expression analysis, BDNF treatment, cerebellar granule cell culture","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — novel subcellular localization finding with functional consequence, single lab, limited mechanistic detail in abstract","pmids":["29467254"],"is_preprint":false},{"year":2019,"finding":"SIRT6 suppresses NFATc4 expression and activation in cardiomyocyte hypertrophy. SIRT6 overexpression represses NFATc4 protein/mRNA, elevates its phosphorylation, prevents nuclear accumulation, and suppresses BNP transcription. The catalytically inactive SIRT6 mutant (H133Y) does not show these effects, indicating dependence on deacetylase activity. SIRT6 physically interacts with NFATc4, suggesting SIRT6-mediated deacetylation of NFATc4.","method":"Adenovirus overexpression, plasmid transfection, catalytic mutant (H133Y), Western blot, immunofluorescence, siRNA rescue, co-immunoprecipitation","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — catalytic mutant controls demonstrate enzyme-dependence, Co-IP shows interaction, multiple readouts, single lab","pmids":["30670969"],"is_preprint":false},{"year":2019,"finding":"RCAN1.4 downregulation via DNMT1/DNMT3b-mediated promoter methylation in liver fibrosis leads to enhanced calcineurin/NFAT3 signaling and hepatic stellate cell activation. RCAN1.4 overexpression alleviates TGF-β1-induced liver fibrosis in a CaN/NFAT3 signaling-dependent manner.","method":"Bisulfite sequencing, ChIP assay (DNMT1/3b binding), rAAV8-RCAN1.4 overexpression in mice, siRNA knockdown, protein-protein interaction network analysis, liver fibrosis model","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms epigenetic regulation of upstream inhibitor, in vivo rescue experiment, mechanistic link to CaN/NFAT3, single lab","pmids":["31285763"],"is_preprint":false},{"year":2020,"finding":"NFATc4 translocates from cytoplasm to nucleus in hepatocytes in NASH. Activated NFATc4 directly binds PPARα in the nucleus and negatively regulates its transcriptional activity, impairing hepatic fatty acid oxidation and increasing lipid deposition. NFATc4 activation increases osteopontin (OPN) production/secretion from hepatocytes, promoting macrophage-mediated inflammation and stellate cell fibrosis via paracrine signaling.","method":"Gain- and loss-of-function (NFATc4 overexpression/knockdown in mice and cells), nuclear fractionation, co-immunoprecipitation (NFATc4-PPARα interaction), NASH mouse model","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct protein interaction (Co-IP), in vivo knockout/overexpression, mechanistic pathway established, single lab with multiple orthogonal approaches","pmids":["32717288"],"is_preprint":false},{"year":2020,"finding":"NFATC4 nuclear translocation is triggered by cisplatin treatment in ovarian cancer cells. NFATC4 activation induces G0 cell cycle arrest, decreased proliferation, and chemotherapy resistance. NFATC4 drives quiescence in part via downregulation of MYC. Inhibition of the NFATC4 pathway increases chemotherapy response.","method":"Nuclear translocation imaging, cell cycle analysis, proliferation assays, MYC expression analysis, gain- and loss-of-function, in vitro and in vivo xenograft models","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function/inhibition with multiple readouts including in vivo, MYC identified as downstream mediator, single lab","pmids":["32182216"],"is_preprint":false},{"year":2020,"finding":"NULP1 directly interacts with the topologically associating domain of NFAT3 via its C-terminal region (confirmed by co-immunoprecipitation), suppressing NFAT3 transcriptional activity. NULP1 knockout exacerbates aortic banding-induced cardiac hypertrophy while NULP1 transgenic overexpression blunts it. The NFAT pathway is identified as the downstream mechanism by VIVIT peptide rescue.","method":"Co-immunoprecipitation, Nulp1 knockout and transgenic mice, aortic banding, VIVIT peptide treatment, NFAT pathway screening, immunostaining","journal":"Journal of the American Heart Association","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP confirms direct interaction, genetic in vivo models with pharmacological rescue, single lab","pmids":["32805187"],"is_preprint":false},{"year":2021,"finding":"SIRT2-mediated deacetylation of NFATc4 inhibits its nuclear translocation and acetylation status in ethanol-exposed hepatocytes. NFATc4 overexpression impairs the negative regulation of RIPK3 and DAMPs release. SIRT2 knockdown abolishes the inhibitory effects of pterostilbene on NFATc4 nuclear translocation and acetylation, placing SIRT2 as an upstream regulator of NFATc4 acetylation.","method":"SIRT2 knockdown, NFATc4 overexpression, Western blot, immunofluorescence, acetylation status analysis, RIPK3/DAMP measurement","journal":"Toxicology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — knockdown epistasis with functional readout, single lab, deacetylation inferred rather than directly demonstrated in vitro","pmids":["34474091"],"is_preprint":false},{"year":2021,"finding":"NFATc4 triggers hepatocyte senescence via repression of PPARγ. NFATc4 knockdown counteracts ethanol-induced hepatocyte senescence markers and protects against alcoholic liver injury. PPARγ deficiency abrogates the inhibitory effects of NFATc4 knockdown on hepatocyte senescence, oxidative stress, and steatosis, placing PPARγ downstream of NFATc4.","method":"siRNA knockdown, PPARγ knockdown epistasis, Western blot, immunofluorescence, senescence-associated β-galactosidase staining, in vivo mouse model","journal":"Toxicology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis through double knockdown, in vivo validation, single lab","pmids":["34192554"],"is_preprint":false},{"year":2022,"finding":"PPP3CA (calcineurin catalytic subunit) promotes dephosphorylation of NFATc4 and suppresses its phosphorylation, facilitating its nuclear translocation. CAMTA1 and PPP3CA competitively bind NFATc4; CAMTA1 knockdown promotes NFATc4 dephosphorylation (and resistance to oxaliplatin) in a PPP3CA-dependent manner. NFATc4 knockdown reverses oxaliplatin resistance caused by CAMTA1 knockdown, establishing a CAMTA1-PPP3CA-NFATc4 complex in colorectal cancer chemoresistance.","method":"Co-immunoprecipitation, competitive binding assay, siRNA knockdown epistasis, Western blot, xenograft mouse model","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — competitive Co-IP, triple epistasis knockdown, in vivo validation, single lab","pmids":["35332122"],"is_preprint":false},{"year":2023,"finding":"Calcineurin (Cn) dephosphorylates NFATC4 (identified by phosphoproteomics) to regulate aldosterone synthase (CYP11B2) expression and aldosterone production in adrenal zona glomerulosa. ZG-specific deletion of calcineurin subunit CnB1 diminishes Cyp11b2 expression and disrupts K+-mediated aldosterone synthesis. Deletion of NFATC4 impairs K+-dependent CYP11B2 stimulation, while constitutively active NFATC4 increases CYP11B2 expression. ChIP confirms NFATC4 directly regulates CYP11B2 promoter.","method":"Phosphoproteomics, ZG-specific CnB1 knockout, NFATC4 knockout, constitutively active NFATC4 expression, ChIP assay, calcineurin inhibitor (tacrolimus) in cell line and ex vivo adrenal tissue","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — phosphoproteomics identifies substrate, multiple genetic models (tissue-specific KO, global KO, constitutively active), ChIP confirms direct target regulation, replicated in human cells and ex vivo tissue","pmids":["37310791"],"is_preprint":false},{"year":2024,"finding":"Mettl1 increases SRSF9 expression by inducing m7G modification of SRSF9 mRNA, which facilitates alternative splicing and stabilization of NFATc4, thereby promoting cardiac hypertrophy. SRSF9 knockdown protects against TAC- or Mettl1-induced cardiac hypertrophy.","method":"Mettl1 knockout/cardiac-specific overexpression in mice, m7G modification assay, SRSF9 knockdown, alternative splicing analysis, TAC and Ang II models","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic chain established (Mettl1→m7G-SRSF9→NFATc4 splicing), in vivo models, single lab","pmids":["38810124"],"is_preprint":false},{"year":2024,"finding":"NFATc4 knockout (but not NFATc3 knockout) increases RGC survival, improves retinal function, and delays axonal degeneration after optic nerve crush. NFATc4 is transiently upregulated and localizes to the ganglion cell layer after injury. Lentiviral re-delivery of NFATc4 to NFATc4-/- retinas reverses the pro-survival effect. NFATc4 knockout suppresses pro-apoptotic signaling (decreased cleaved caspase-3).","method":"NFATc4-/- and NFATc3-/- mice, optic nerve crush, lentiviral NFATc4 delivery rescue, microarray screening, immunostaining, retinal function testing","journal":"Molecular neurobiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — isoform-specific knockout with genetic rescue, microarray mechanism screen, isoform specificity confirmed by NFATc3 KO comparison, single lab","pmids":["38639863"],"is_preprint":false},{"year":2019,"finding":"NFATc4 mediates expression of TNF and downstream hair cell apoptosis in the cochlea after ototoxic drug challenge. In Nfatc4-/- mice, hair cells show lower sensitivity to ototoxic damage and noise exposure, and the TNF-mediated apoptosis pathway is attenuated. NFATc4 is activated (nuclear translocation) in cochlear hair cells upon ototoxic challenge.","method":"Nfatc4-/- mice, ototoxic drug treatment, noise exposure, TNF and apoptosis pathway analysis, immunostaining","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse with defined molecular pathway (NFATc4→TNF→apoptosis), single lab","pmids":["31379853"],"is_preprint":false},{"year":2007,"finding":"IL-18 suppresses adiponectin transcription via ERK1/2-dependent NFATc4 phosphorylation at Ser676 and NFATc4 nuclear translocation and in vivo DNA binding to the adiponectin promoter. IL-18 deletion or mutation of the NFATc4 core DNA-binding site in the adiponectin promoter-reporter reverses IL-18-mediated suppression. Inhibition of ERK1/2 attenuates NFATc4 Ser676 phosphorylation.","method":"Reporter assays with promoter mutation, ChIP (in vivo DNA binding), ERK inhibitors/siRNA, NFATc4 siRNA knockdown, nuclear translocation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — direct promoter binding confirmed by ChIP, mutagenesis of binding site, ERK1/2 epistasis, multiple methods, single lab","pmids":["18086672"],"is_preprint":false},{"year":2004,"finding":"NFATc4 forms a ternary transcriptional complex with Nishéd and co-activator p300 at an intronic regulatory element (IRE) of the MLC-2v gene in cardiomyocytes. This complex formation is enhanced by angiotensin II stimulation. Losartan (AT1 receptor antagonist) abolishes agonist-dependent IRE-complex interaction and MLC-2v transcription.","method":"Gel mobility shift assay (EMSA), co-immunoprecipitation, reporter assays, pharmacological inhibition","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ternary complex demonstrated by EMSA and Co-IP, pharmacological epistasis, single lab","pmids":["15272022"],"is_preprint":false},{"year":2008,"finding":"NFAT3 activity requires AP-1 co-binding for transcriptional activation; an NFAT3 promoter containing the NFAT core cis-element without an adjacent AP-1 binding site fails to show activation by H2O2 treatment. Dominant-negative c-Jun (TAM67) prevents H2O2 or ANG II from activating the NFAT3 promoter. ERK inhibition blocks AP-1 and NFAT3 activation.","method":"Promoter-luciferase reporter with AP-1 site mutations, dominant-negative c-Jun cotransfection, ERK pharmacological inhibition","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional promoter mutagenesis and dominant-negative epistasis, single lab","pmids":["17108007"],"is_preprint":false}],"current_model":"NFATc4 (NFAT3) is a calcium/calcineurin-regulated transcription factor that, upon dephosphorylation by calcineurin, translocates from the cytoplasm to the nucleus to activate target gene transcription; its activity is controlled by multiple kinases that phosphorylate gate-keeping serine residues (GSK-3 at export, p38 MAPK/mTOR/ERK5 at Ser168/170, RSK/ERK at Ser676, CDK3 at Ser259) to promote nuclear export or modulate transcriptional activity, by ubiquitin-proteasome degradation, and by post-translational modifications including deacetylation by SIRT6 and SIRT2; it forms functional complexes with CBP (via two distinct transactivation domains), FoxP1, GATA-4, myocardin, PPARα, estrogen receptors, p300/Nishéd, and NULP1, and directly regulates a broad array of target genes (including BDNF, GAP-43, PPARγ2, Adss1, MLC-2v, LTCC α1C, FasL, CYP11B2, Kv4.2, BACE1, LCN2, adiponectin, and pro-inflammatory cytokines) in diverse tissues including heart, neurons, adipose, liver, cochlea, adrenal gland, and immune cells."},"narrative":{"mechanistic_narrative":"NFATc4 (NFAT3) is a calcium/calcineurin-regulated transcription factor that, upon dephosphorylation of gate-keeping serines, translocates from the cytoplasm to the nucleus to control programs of cell survival, differentiation, and stress adaptation across neurons, heart, liver, adipose, adrenal, and immune tissues [PMID:10537109, PMID:37310791]. Calcium entry — through L-type voltage-gated channels in neurons or in response to depolarization, growth-factor, and Gq/Ras signaling — activates calcineurin (PPP3CA), which dephosphorylates NFATc4 and drives nuclear import, an event placed downstream of Ras/MEK/ERK in cardiomyocytes [PMID:10537109, PMID:11044444, PMID:37310791]. Nuclear residence is opposed by a layered kinase network: GSK-3 phosphorylates NFATc4 to promote nuclear export, mTOR and ERK5 maintain or restore phosphorylation of the gate-keeping Ser168/170 (ERK5 priming subsequent CK1α phosphorylation), and the serine-proline repeat region sets its characteristically slow, prolonged translocation kinetics relative to NFATc3 [PMID:10537109, PMID:18347059, PMID:22977251]. By contrast, RSK/ERK phosphorylation at Ser676 and CDK3 phosphorylation at Ser259 potentiate DNA binding and transactivation, while p38 phosphorylation of Ser168/170 restrains nuclear localization [PMID:11997522, PMID:15657420, PMID:17213202, PMID:27893713]. NFATc4 acts through two transactivation domains that engage distinct CBP regions and partners with p300/Nishé to build transcription complexes, and its output is further tuned by competing repressors (FoxP1, lipin-1, NULP1) and by acetylation/deacetylation through SIRT6 and SIRT2 and Lys48 ubiquitin-proteasome turnover [PMID:11997522, PMID:11514544, PMID:15657420, PMID:27893713, PMID:20385772, PMID:21606195, PMID:30670969, PMID:32805187, PMID:15272022, PMID:34474091, PMID:19026640]. Functionally it can both activate and repress targets: it drives pro-survival BDNF and GABAA-receptor subunit programs and Kv4.2 in neurons, regulates CYP11B2/aldosterone synthesis in adrenal zona glomerulosa, and synergizes with myocardin and supports mitochondrial maturation in heart, yet represses GAP-43 in neurons and antagonizes PPARα/PPARγ in hepatocytes [PMID:19955386, PMID:24948817, PMID:27307045, PMID:37310791, PMID:27155398, PMID:12750314, PMID:19443652, PMID:32717288, PMID:34192554]. Genetically, NFATc4 is dispensable for calcineurin-induced cardiac hypertrophy but, redundantly with NFATc3, is required for embryonic cardiac development and mitochondrial respiratory function [PMID:12370307, PMID:12750314]. Across injury and disease contexts it functions as a stress-induced effector — driving FasL- and TNF-mediated apoptosis in cochlear and ototoxin-challenged neurons, RGC degeneration after optic nerve injury, OPN-driven hepatic inflammation in NASH, and MYC-suppression-linked quiescence and chemoresistance in ovarian and colorectal cancer [PMID:18354019, PMID:31379853, PMID:38639863, PMID:32717288, PMID:32182216, PMID:35332122].","teleology":[{"year":1999,"claim":"Established the core activation logic of NFATc4 in excitable cells: how an extracellular electrical/calcium signal is converted into a nuclear transcriptional response.","evidence":"K+ depolarization with calcineurin/L-type Ca2+ channel pharmacology, GSK-3 kinase and reporter assays in hippocampal neurons","pmids":["10537109"],"confidence":"High","gaps":["Did not identify endogenous target genes activated in neurons","Mechanism of GSK-3-driven export not resolved at residue level"]},{"year":2000,"claim":"Defined upstream signaling specificity in heart, showing Ras/MEK/ERK acts above calcineurin to drive NFAT3 activation and that NFAT3 directly activates a metabolic target.","evidence":"Constitutively active/dominant-negative Ras and GTPase mutants, calcineurin assays, and Adss1 promoter mutagenesis in cardiomyocytes","pmids":["11044444","10636885"],"confidence":"High","gaps":["How ERK signaling intersects calcineurin biochemically was not defined","Adss1 regulation was correlative beyond a single binding site"]},{"year":2001,"claim":"Mapped the coactivator interface, showing NFATc4 uses two transactivation domains binding distinct CBP regions, defining how it recruits transcriptional machinery.","evidence":"Deletion mutagenesis, Co-IP, and in vitro binding with reporter assays","pmids":["11514544"],"confidence":"High","gaps":["Structural basis of the dual interaction not resolved","Context-dependence of CBP recruitment at native promoters untested"]},{"year":2002,"claim":"Identified phosphorylation gate-keeping (p38 at Ser168/170) and provided in vivo genetic proof that NFATc4 is dispensable for cardiac hypertrophy, separating its function from the redundant paralog NFATc3.","evidence":"In vitro kinase assays with S168/170A mutagenesis and adipocyte differentiation; NFATc4 vs NFATc3 knockout mice in multiple hypertrophy models","pmids":["11997522","12370307"],"confidence":"High","gaps":["Functional redundancy with NFATc3 in heart not yet defined","PPARγ2 regulation shown in cell lines only"]},{"year":2003,"claim":"Resolved the developmental requirement, showing NFATc3/c4 are jointly essential for cardiac morphogenesis and mitochondrial respiratory function, with NFATc4 alone sufficient to rescue.","evidence":"Double-knockout mice with cardiac-specific constitutively active NFATc4 rescue, EM and respiratory chain enzymology","pmids":["12750314"],"confidence":"High","gaps":["Direct mitochondrial/proliferative target genes not identified","Mechanism of complex II/IV regulation unknown"]},{"year":2004,"claim":"Extended the coactivator model to native cardiac loci, showing NFATc4 forms a Nishéd/p300 ternary complex at the MLC-2v enhancer under angiotensin II/AT1 signaling.","evidence":"EMSA, Co-IP, reporter assays with losartan in cardiomyocytes","pmids":["15272022"],"confidence":"Medium","gaps":["Nishéd identity/role only partially defined","Direct vs bridged contacts within the ternary complex unresolved"]},{"year":2005,"claim":"Defined two positive regulatory branches: RSK recruitment to the NFATc4-DNA complex (Ser676) enhancing DNA binding, and ligand-independent cooperation with estrogen receptors.","evidence":"DNA affinity isolation/in-gel kinase assays and EMSA; yeast two-hybrid, GST pulldown, Co-IP, and ChIP at estrogen-responsive promoters","pmids":["15657420","16219765"],"confidence":"High","gaps":["Physiological contexts of ER cooperation limited","How RSK access to the DNA-bound complex is regulated unclear"]},{"year":2007,"claim":"Connected RSK2/ERK signaling to a differentiation program and to metabolic gene repression, showing NFATc4 drives myotube formation and mediates IL-18 suppression of adiponectin.","evidence":"In vitro kinase assays with Km, Co-IP, siRNA, C2C12 differentiation; ChIP and promoter mutagenesis with ERK epistasis on the adiponectin promoter","pmids":["17213202","18086672"],"confidence":"High","gaps":["Direct myogenic target genes not enumerated","Ser676 phosphorylation as activator vs the export-promoting kinases not reconciled"]},{"year":2008,"claim":"Built the multi-kinase shuttling and degradation control circuit, identifying mTOR as a basal cytosolic-retention kinase, ERK5/CK1α as a rephosphorylation/export module, AP-1 as an obligate co-binding partner, and Lys48 ubiquitination as a stability switch.","evidence":"Phospho-specific antibodies and Erk5-/- cells; promoter mutagenesis with dominant-negative c-Jun; ubiquitination assays with GSK3β manipulation","pmids":["18347059","17108007","19026640"],"confidence":"High","gaps":["E3 ligase mediating Lys48 ubiquitination not identified","Ubiquitination finding rests on a single Medium-confidence study"]},{"year":2008,"claim":"Demonstrated tissue-specific apoptotic roles, showing NFATc4 drives FasL-dependent neuronal death in the cochlear nucleus after deafferentation during a critical period.","evidence":"In vivo cochlea removal with FK506 and 11R-VIVIT inhibitors, apoptosis and FasL assays","pmids":["18354019"],"confidence":"Medium","gaps":["Direct FasL promoter occupancy by NFATc4 not shown here","Reconciliation with pro-survival neuronal roles unresolved"]},{"year":2009,"claim":"Resolved the dual activator/repressor nature in neurons, showing NFATc4 directly represses GAP-43 yet sustains pro-survival BDNF promoter IV transcription downstream of NMDAR.","evidence":"ChIP in cells and brain with overexpression for GAP-43; RNAi knockdown with BDNF rescue and promoter IV reporters","pmids":["19443652","19955386"],"confidence":"High","gaps":["What determines activator vs repressor mode at a given promoter is unknown","Cofactors mediating GAP-43 repression not identified"]},{"year":2010,"claim":"Identified direct protein repressors and a cancer-relevant target, showing lipin-1 binds and represses NFATc4 (likely via HDAC recruitment) and NFAT3 suppresses LCN2 to restrain breast cancer cell motility.","evidence":"Co-IP, ChIP, lipin-1 knockout/siRNA in adipocytes; siRNA with migration/invasion and actin assays in ERα+ breast cancer","pmids":["20385772","20101218"],"confidence":"High","gaps":["HDAC identity in lipin-1 repression not confirmed","LCN2 regulation mechanistically shallow (Medium confidence)"]},{"year":2011,"claim":"Established a direct cardiac antagonist, showing FoxP1 binds NFATc4 upon calcineurin activation and co-occupies hypertrophy gene promoters to oppose their activation.","evidence":"BiFC, Co-IP, interface mutagenesis, ChIP in native heart tissue, hypertrophy reporter assays","pmids":["21606195"],"confidence":"High","gaps":["Whether FoxP1 recruits corepressors or blocks DNA binding not distinguished","In vivo phenotype of the complex not tested by genetics"]},{"year":2012,"claim":"Defined kinetic and physiological distinctness from NFATc3, showing NFATc4 translocates slowly (controlled by its Ser-Pro repeat and GSK3β) and is specifically required for BDNF-dependent adult neurogenesis, LTP, and spatial memory.","evidence":"NFATc3/c4 chimeras and kinase knockdowns with live imaging; NFATc4 knockout mice with CsA/TrkB-Fc, BrdU survival, LTP, and behavior","pmids":["22977251","22586092"],"confidence":"High","gaps":["Why p38/mTOR inhibition lacked effect on neuronal import vs other systems unexplained","Direct neurogenesis target genes not identified"]},{"year":2013,"claim":"Extended direct target repertoire to a microRNA and chondrocyte signaling, showing NFAT3 binds and activates the miR-140 regulatory sequence and is antagonized by TGF-β.","evidence":"siRNA, luciferase with binding-site mutagenesis, ChIP, immunocytochemistry","pmids":["24257415"],"confidence":"Medium","gaps":["Physiological role of NFAT3-miR-140 axis not established in vivo","Interplay with SMAD3 only partially defined"]},{"year":2014,"claim":"Added neurodevelopmental gene targets, showing NFATc4 directly regulates GABAA receptor subunits GABRA2/GABRA4 to couple GABA signaling to hippocampal neurogenesis.","evidence":"Genome-wide screen, ChIP, luciferase, calcineurin inhibition, NFATc4 knockout mice, behavior","pmids":["24948817"],"confidence":"High","gaps":["Activator vs repressor mode at these promoters not detailed","Link between subunit expression and behavioral output indirect"]},{"year":2015,"claim":"Implicated NFATc4 in Alzheimer-relevant transcription, showing it directly binds the BACE1 promoter to increase BACE1 and Aβ production.","evidence":"ChIP, reporter, overexpression/siRNA, Aβ measurement, APP/PS1 mice","pmids":["25663301"],"confidence":"Medium","gaps":["No causal genetic test of NFATc4 in AD models","Single Medium-confidence study"]},{"year":2016,"claim":"Identified an additional activating kinase and direct cardiac/neuronal targets: CDK3 phosphorylates Ser259 to drive transformation, NFATc4 synergizes with myocardin for LTCC α1C, and mediates neuritin-induced Kv4.2 expression.","evidence":"In vitro kinase/two-hybrid with S259A and xenografts; Co-IP and ChIP for myocardin/LTCC; NFATc4 vs NFATc2 knockout mice and ChIP for Kv4.2","pmids":["27893713","27155398","27307045"],"confidence":"High","gaps":["Hierarchy among the multiple activating phosphorylation sites unresolved","Myocardin study Medium confidence"]},{"year":2017,"claim":"Defined an immune-suppressive role distinct from other NFAT family members, showing NFAT3 represses IL-2 (opposite to NFAT1) under TBX5 control.","evidence":"RNAi, NFAT1/NFAT3 chimeras, promoter mutagenesis, TBX5 overexpression in T cells","pmids":["29180489"],"confidence":"Medium","gaps":["Mechanism of repression (cofactor recruitment) not defined","In vivo immune phenotype untested"]},{"year":2018,"claim":"Revealed a non-canonical extranuclear regulatory mode, showing BDNF sequesters NFATc4 in the Golgi to relieve its repressor activity and time an NFI gene program.","evidence":"Subcellular fractionation/imaging and NFI target expression in cerebellar granule cells","pmids":["29467254"],"confidence":"Medium","gaps":["Molecular basis of Golgi sequestration unknown","Limited mechanistic detail (Medium confidence)"]},{"year":2019,"claim":"Established acetylation control and disease roles, showing SIRT6 deacetylase activity suppresses NFATc4 in cardiac hypertrophy and NFATc4 drives TNF-mediated cochlear hair-cell apoptosis.","evidence":"Adenoviral SIRT6 with catalytic mutant H133Y and Co-IP; Nfatc4-/- mice with ototoxic/noise challenge and TNF/apoptosis analysis","pmids":["30670969","31379853"],"confidence":"Medium","gaps":["Direct deacetylated lysine residues not mapped","SIRT6 effect on protein level vs activity entangled"]},{"year":2019,"claim":"Placed NFATc4 within an epigenetically controlled fibrotic axis, showing RCAN1.4 silencing de-represses calcineurin/NFAT3 to drive hepatic stellate cell activation.","evidence":"Bisulfite sequencing, ChIP of DNMTs, rAAV8-RCAN1.4 rescue in liver fibrosis model","pmids":["31285763"],"confidence":"Medium","gaps":["Direct fibrotic target genes of NFAT3 not defined","RCAN1.4 effect on NFAT3 inferred via calcineurin"]},{"year":2020,"claim":"Defined hepatic metabolic and inflammatory mechanisms, showing nuclear NFATc4 binds and inhibits PPARα to impair fatty acid oxidation and induces OPN to drive NASH inflammation/fibrosis, while in cancer it induces MYC-low quiescence and chemoresistance.","evidence":"Co-IP and in vivo gain/loss-of-function in NASH; nuclear translocation, cell-cycle, MYC analysis and xenografts in ovarian cancer","pmids":["32717288","32182216"],"confidence":"High","gaps":["Whether OPN is a direct NFATc4 target promoter untested","Mechanism of MYC downregulation not resolved"]},{"year":2020,"claim":"Identified an additional cardiac repressor, showing NULP1 directly binds NFAT3 and blunts pressure-overload hypertrophy through NFAT pathway suppression.","evidence":"Co-IP, Nulp1 knockout/transgenic mice, aortic banding, VIVIT peptide rescue","pmids":["32805187"],"confidence":"High","gaps":["Whether NULP1 blocks DNA binding or recruits corepressors not distinguished","Target genes affected not enumerated"]},{"year":2021,"claim":"Extended acetylation regulation and hepatic injury mechanisms, showing SIRT2 deacetylation inhibits NFATc4 nuclear translocation and NFATc4 drives PPARγ-dependent hepatocyte senescence in alcoholic liver injury.","evidence":"SIRT2 knockdown epistasis with acetylation/RIPK3 readouts; NFATc4/PPARγ double knockdown with senescence assays in vivo","pmids":["34474091","34192554"],"confidence":"Medium","gaps":["Direct deacetylation of NFATc4 by SIRT2 inferred, not shown in vitro","PPARγ repression mechanism (direct vs indirect) unclear"]},{"year":2022,"claim":"Defined a competitive scaffolding mechanism for activation, showing CAMTA1 and PPP3CA competitively bind NFATc4 to set its phosphorylation/activation and chemoresistance in colorectal cancer.","evidence":"Competitive Co-IP, triple siRNA epistasis, xenografts","pmids":["35332122"],"confidence":"Medium","gaps":["Direct CAMTA1-NFATc4 contact vs bridged interaction unresolved","Target genes mediating chemoresistance not identified"]},{"year":2023,"claim":"Provided definitive substrate-level and target-level proof in an endocrine context, identifying NFATC4 as a calcineurin substrate that directly drives CYP11B2 and K+-dependent aldosterone synthesis.","evidence":"Phosphoproteomics, ZG-specific CnB1 knockout, NFATC4 knockout and constitutively active expression, ChIP, ex vivo human/adrenal tissue","pmids":["37310791"],"confidence":"High","gaps":["Phosphosites dephosphorylated by calcineurin in adrenal not mapped","Cofactors at the CYP11B2 promoter not defined"]},{"year":2024,"claim":"Added post-transcriptional control and reinforced isoform-specific injury roles, showing Mettl1/m7G-SRSF9 splicing stabilizes NFATc4 to promote hypertrophy and that NFATc4 (not NFATc3) drives retinal ganglion cell death after injury.","evidence":"Mettl1 mouse models with m7G and SRSF9 knockdown in TAC; NFATc4-/- vs NFATc3-/- mice with lentiviral rescue and microarray after optic nerve crush","pmids":["38810124","38639863"],"confidence":"Medium","gaps":["NFATc4 splice isoforms regulated by SRSF9 not characterized","RGC pro-apoptotic target genes only screened, not validated"]},{"year":null,"claim":"What determines whether activated NFATc4 acts as a transcriptional activator versus repressor at a given promoter, and how the many competing kinases, deacetylases, and protein partners are integrated in vivo within a single cell type, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model reconciling activating (Ser259/Ser676) vs export-promoting phosphorylation","Genome-wide direct target maps largely absent across tissues","Structural basis of partner-driven activator/repressor switching unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,14,22,23,26,37,41]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,9,14,23,26,37,41]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,7,20,31,37]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,11,20]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[28]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,14,37,41]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,11,37]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[7,13,15,39,40]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,10,22]}],"complexes":[],"partners":["CBP","FOXP1","MYOCARDIN","PPARA","ESR1","NULP1","PPP3CA","RPS6KA2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q14934","full_name":"Nuclear factor of activated T-cells, cytoplasmic 4","aliases":["T-cell transcription factor NFAT3","NF-AT3"],"length_aa":902,"mass_kda":95.4,"function":"Ca(2+)-regulated transcription factor that is involved in several processes, including the development and function of the immune, cardiovascular, musculoskeletal, and nervous systems (PubMed:11514544, PubMed:11997522, PubMed:17213202, PubMed:17875713, PubMed:18668201, PubMed:25663301, PubMed:7749981). Involved in T-cell activation, stimulating the transcription of cytokine genes, including that of IL2 and IL4 (PubMed:18347059, PubMed:18668201, PubMed:7749981). Along with NFATC3, involved in embryonic heart development. Following JAK/STAT signaling activation and as part of a complex with NFATC3 and STAT3, binds to the alpha-beta E4 promoter region of CRYAB and activates transcription in cardiomyocytes (By similarity). Involved in mitochondrial energy metabolism required for cardiac morphogenesis and function (By similarity). Transactivates many genes involved in the cardiovascular system, including AGTR2, NPPB/BNP (in synergy with GATA4), NPPA/ANP/ANF and MYH7/beta-MHC (By similarity). Involved in the regulation of adult hippocampal neurogenesis. Involved in BDNF-driven pro-survival signaling in hippocampal adult-born neurons. Involved in the formation of long-term spatial memory and long-term potentiation (By similarity). In cochlear nucleus neurons, may play a role in deafferentation-induced apoptosis during the developmental critical period, when auditory neurons depend on afferent input for survival (By similarity). Binds to and activates the BACE1/Beta-secretase 1 promoter, hence may regulate the proteolytic processing of the amyloid precursor protein (APP) (PubMed:25663301). Plays a role in adipocyte differentiation (PubMed:11997522). May be involved in myoblast differentiation into myotubes (PubMed:17213202). Binds the consensus DNA sequence 5'-GGAAAAT-3' (Probable). In the presence of CREBBP, activates TNF transcription (PubMed:11514544). Binds to PPARG gene promoter and regulates its activity (PubMed:11997522). Binds to PPARG and REG3G gene promoters (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q14934/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NFATC4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NFATC4","total_profiled":1310},"omim":[{"mim_id":"609618","title":"NONCODING REPRESSOR OF NFAT; NRON","url":"https://www.omim.org/entry/609618"},{"mim_id":"608431","title":"G3BP STRESS GRANULE ASSEMBLY FACTOR 1; G3BP1","url":"https://www.omim.org/entry/608431"},{"mim_id":"602699","title":"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4; NFATC4","url":"https://www.omim.org/entry/602699"},{"mim_id":"602698","title":"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 3; NFATC3","url":"https://www.omim.org/entry/602698"},{"mim_id":"602229","title":"SRY-BOX 10; SOX10","url":"https://www.omim.org/entry/602229"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NFATC4"},"hgnc":{"alias_symbol":["NFAT3"],"prev_symbol":[]},"alphafold":{"accession":"Q14934","domains":[{"cath_id":"2.60.40.340","chopping":"398-577","consensus_level":"high","plddt":92.331,"start":398,"end":577},{"cath_id":"2.60.40.10","chopping":"588-685","consensus_level":"high","plddt":93.7858,"start":588,"end":685}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14934","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q14934-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q14934-F1-predicted_aligned_error_v6.png","plddt_mean":58.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NFATC4","jax_strain_url":"https://www.jax.org/strain/search?query=NFATC4"},"sequence":{"accession":"Q14934","fasta_url":"https://rest.uniprot.org/uniprotkb/Q14934.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q14934/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q14934"}},"corpus_meta":[{"pmid":"10537109","id":"PMC_10537109","title":"L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10537109","citation_count":436,"is_preprint":false},{"pmid":"12370307","id":"PMC_12370307","title":"Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12370307","citation_count":218,"is_preprint":false},{"pmid":"11997522","id":"PMC_11997522","title":"Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11997522","citation_count":146,"is_preprint":false},{"pmid":"12750314","id":"PMC_12750314","title":"NFATc3 and NFATc4 are required for cardiac development and mitochondrial function.","date":"2003","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/12750314","citation_count":122,"is_preprint":false},{"pmid":"15537643","id":"PMC_15537643","title":"The transcription factor NFAT3 mediates neuronal survival.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15537643","citation_count":102,"is_preprint":false},{"pmid":"20385772","id":"PMC_20385772","title":"Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20385772","citation_count":97,"is_preprint":false},{"pmid":"10636885","id":"PMC_10636885","title":"Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10636885","citation_count":94,"is_preprint":false},{"pmid":"11044444","id":"PMC_11044444","title":"Ras regulates NFAT3 activity in cardiac myocytes.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11044444","citation_count":90,"is_preprint":false},{"pmid":"20173049","id":"PMC_20173049","title":"NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.","date":"2010","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20173049","citation_count":83,"is_preprint":false},{"pmid":"25132256","id":"PMC_25132256","title":"Effect of Astragalus polysaccharides on expression of TNF-α, IL-1β and NFATc4 in a rat model of experimental colitis.","date":"2014","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/25132256","citation_count":79,"is_preprint":false},{"pmid":"17213202","id":"PMC_17213202","title":"RSK2 mediates muscle cell differentiation through regulation of NFAT3.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17213202","citation_count":65,"is_preprint":false},{"pmid":"24257415","id":"PMC_24257415","title":"NFAT3 and TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis.","date":"2013","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24257415","citation_count":61,"is_preprint":false},{"pmid":"19955386","id":"PMC_19955386","title":"Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19955386","citation_count":59,"is_preprint":false},{"pmid":"16219765","id":"PMC_16219765","title":"Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16219765","citation_count":53,"is_preprint":false},{"pmid":"22586092","id":"PMC_22586092","title":"Nuclear factor of activated T cells (NFATc4) is required for BDNF-dependent survival of adult-born neurons and spatial memory formation in the hippocampus.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22586092","citation_count":50,"is_preprint":false},{"pmid":"20101218","id":"PMC_20101218","title":"NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20101218","citation_count":49,"is_preprint":false},{"pmid":"31285763","id":"PMC_31285763","title":"Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31285763","citation_count":48,"is_preprint":false},{"pmid":"15657420","id":"PMC_15657420","title":"Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15657420","citation_count":47,"is_preprint":false},{"pmid":"18354019","id":"PMC_18354019","title":"Deafferentation-induced activation of NFAT (nuclear factor of activated T-cells) in cochlear nucleus neurons during a developmental critical period: a role for NFATc4-dependent apoptosis in the CNS.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18354019","citation_count":44,"is_preprint":false},{"pmid":"23518069","id":"PMC_23518069","title":"Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4.","date":"2013","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23518069","citation_count":44,"is_preprint":false},{"pmid":"32182216","id":"PMC_32182216","title":"NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32182216","citation_count":43,"is_preprint":false},{"pmid":"38810124","id":"PMC_38810124","title":"The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9-Mediated Splicing of NFATc4.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38810124","citation_count":41,"is_preprint":false},{"pmid":"16803872","id":"PMC_16803872","title":"NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16803872","citation_count":41,"is_preprint":false},{"pmid":"18275974","id":"PMC_18275974","title":"T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.","date":"2007","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18275974","citation_count":40,"is_preprint":false},{"pmid":"18347059","id":"PMC_18347059","title":"Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18347059","citation_count":39,"is_preprint":false},{"pmid":"32717288","id":"PMC_32717288","title":"Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.","date":"2020","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/32717288","citation_count":38,"is_preprint":false},{"pmid":"22977251","id":"PMC_22977251","title":"Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22977251","citation_count":37,"is_preprint":false},{"pmid":"24948817","id":"PMC_24948817","title":"Modulation of GABAA receptor signaling increases neurogenesis and suppresses anxiety through NFATc4.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24948817","citation_count":36,"is_preprint":false},{"pmid":"19443652","id":"PMC_19443652","title":"NFAT-3 is a transcriptional repressor of the growth-associated protein 43 during neuronal maturation.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19443652","citation_count":34,"is_preprint":false},{"pmid":"30670969","id":"PMC_30670969","title":"SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30670969","citation_count":33,"is_preprint":false},{"pmid":"22234350","id":"PMC_22234350","title":"Genetic polymorphisms of the transcription factor NFATc4 and development of new-onset diabetes after transplantation in Hispanic kidney transplant recipients.","date":"2012","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/22234350","citation_count":33,"is_preprint":false},{"pmid":"18086672","id":"PMC_18086672","title":"Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18086672","citation_count":32,"is_preprint":false},{"pmid":"22198280","id":"PMC_22198280","title":"PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.","date":"2011","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/22198280","citation_count":32,"is_preprint":false},{"pmid":"27307045","id":"PMC_27307045","title":"Neuritin Up-regulates Kv4.2 α-Subunit of Potassium Channel Expression and Affects Neuronal Excitability by Regulating the Calcium-Calcineurin-NFATc4 Signaling Pathway.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27307045","citation_count":31,"is_preprint":false},{"pmid":"27893713","id":"PMC_27893713","title":"Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27893713","citation_count":30,"is_preprint":false},{"pmid":"21606195","id":"PMC_21606195","title":"Opposing roles of FoxP1 and Nfat3 in transcriptional control of cardiomyocyte hypertrophy.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21606195","citation_count":30,"is_preprint":false},{"pmid":"34474091","id":"PMC_34474091","title":"Pterostilbene attenuates RIPK3-dependent hepatocyte necroptosis in alcoholic liver disease via SIRT2-mediated NFATc4 deacetylation.","date":"2021","source":"Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34474091","citation_count":28,"is_preprint":false},{"pmid":"31539560","id":"PMC_31539560","title":"Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.","date":"2019","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/31539560","citation_count":28,"is_preprint":false},{"pmid":"18668201","id":"PMC_18668201","title":"Repression of NFAT3 transcriptional activity by estrogen receptors.","date":"2008","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/18668201","citation_count":27,"is_preprint":false},{"pmid":"23852416","id":"PMC_23852416","title":"Up-regulation of NFATc4 involves in neuronal apoptosis following intracerebral hemorrhage.","date":"2013","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23852416","citation_count":27,"is_preprint":false},{"pmid":"20718735","id":"PMC_20718735","title":"Activation of a nuclear factor of activated T-lymphocyte-3 (NFAT3) by oxidative stress in carboplatin-mediated renal apoptosis.","date":"2010","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20718735","citation_count":27,"is_preprint":false},{"pmid":"26235896","id":"PMC_26235896","title":"Transcriptional Profiling of Hypoxic Neural Stem Cells Identifies Calcineurin-NFATc4 Signaling as a Major Regulator of Neural Stem Cell Biology.","date":"2015","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26235896","citation_count":26,"is_preprint":false},{"pmid":"16055480","id":"PMC_16055480","title":"Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle.","date":"2005","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16055480","citation_count":25,"is_preprint":false},{"pmid":"11514544","id":"PMC_11514544","title":"Requirement of two NFATc4 transactivation domains for CBP potentiation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11514544","citation_count":24,"is_preprint":false},{"pmid":"34192554","id":"PMC_34192554","title":"NFATc4 mediates ethanol-triggered hepatocyte senescence.","date":"2021","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34192554","citation_count":23,"is_preprint":false},{"pmid":"19784808","id":"PMC_19784808","title":"Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.","date":"2009","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/19784808","citation_count":22,"is_preprint":false},{"pmid":"29977601","id":"PMC_29977601","title":"Controllability in an islet specific regulatory network identifies the transcriptional factor NFATC4, which regulates Type 2 Diabetes associated genes.","date":"2018","source":"NPJ systems biology and applications","url":"https://pubmed.ncbi.nlm.nih.gov/29977601","citation_count":22,"is_preprint":false},{"pmid":"17108007","id":"PMC_17108007","title":"Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor.","date":"2006","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17108007","citation_count":21,"is_preprint":false},{"pmid":"15272022","id":"PMC_15272022","title":"A ternary complex of transcription factors, Nishéd and NFATc4, and co-activator p300 bound to an intronic sequence, intronic regulatory element, is pivotal for the up-regulation of myosin light chain-2v gene in cardiac hypertrophy.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15272022","citation_count":21,"is_preprint":false},{"pmid":"25090113","id":"PMC_25090113","title":"L-carnitine protects against carboplatin-mediated renal injury: AMPK- and PPARα-dependent inactivation of NFAT3.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25090113","citation_count":20,"is_preprint":false},{"pmid":"26056815","id":"PMC_26056815","title":"KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.","date":"2015","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/26056815","citation_count":19,"is_preprint":false},{"pmid":"17522069","id":"PMC_17522069","title":"Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells.","date":"2007","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/17522069","citation_count":19,"is_preprint":false},{"pmid":"16273547","id":"PMC_16273547","title":"Immunolocalization of NFATc4 in the adult mouse brain.","date":"2005","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/16273547","citation_count":18,"is_preprint":false},{"pmid":"24583134","id":"PMC_24583134","title":"Interleukin-13-induced MUC5AC expression is regulated by a PI3K-NFAT3 pathway in mouse tracheal epithelial cells.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24583134","citation_count":17,"is_preprint":false},{"pmid":"29180489","id":"PMC_29180489","title":"Downregulation of NFAT3 Due to Lack of T-Box Transcription Factor TBX5 Is Crucial for Cytokine Expression in T Cells.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29180489","citation_count":17,"is_preprint":false},{"pmid":"29225169","id":"PMC_29225169","title":"Inhibition of Orai1-mediated Ca2+ entry limits endothelial cell inflammation by suppressing calcineurin-NFATc4 signaling pathway.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29225169","citation_count":16,"is_preprint":false},{"pmid":"25663301","id":"PMC_25663301","title":"Transcriptional regulation of BACE1 by NFAT3 leads to enhanced amyloidogenic processing.","date":"2015","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/25663301","citation_count":16,"is_preprint":false},{"pmid":"22686291","id":"PMC_22686291","title":"Dopamine D1 receptors regulate type 1 inositol 1,4,5-trisphosphate receptor expression via both AP-1- and NFATc4-mediated transcriptional processes.","date":"2012","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22686291","citation_count":16,"is_preprint":false},{"pmid":"19026640","id":"PMC_19026640","title":"Regulation of the stability and transcriptional activity of NFATc4 by ubiquitination.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19026640","citation_count":15,"is_preprint":false},{"pmid":"31379853","id":"PMC_31379853","title":"Nfatc4 Deficiency Attenuates Ototoxicity by Suppressing Tnf-Mediated Hair Cell Apoptosis in the Mouse Cochlea.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31379853","citation_count":15,"is_preprint":false},{"pmid":"16475165","id":"PMC_16475165","title":"Knockdown of NFAT3 blocked TPA-induced COX-2 and iNOS expression, and enhanced cell transformation in Cl41 cells.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16475165","citation_count":15,"is_preprint":false},{"pmid":"23597509","id":"PMC_23597509","title":"Regulation of type 1 IP₃ receptor expression by dopamine D2-like receptors via AP-1 and NFATc4 activation.","date":"2013","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23597509","citation_count":15,"is_preprint":false},{"pmid":"20852920","id":"PMC_20852920","title":"BNIP3 induces IL6 and calcineurin/NFAT3 hypertrophic-related pathways in H9c2 cardiomyoblast cells.","date":"2010","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20852920","citation_count":15,"is_preprint":false},{"pmid":"29467254","id":"PMC_29467254","title":"BDNF activates an NFI-dependent neurodevelopmental timing program by sequestering NFATc4.","date":"2018","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/29467254","citation_count":15,"is_preprint":false},{"pmid":"37310791","id":"PMC_37310791","title":"Calcineurin regulates aldosterone production via dephosphorylation of NFATC4.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/37310791","citation_count":13,"is_preprint":false},{"pmid":"27155398","id":"PMC_27155398","title":"NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy.","date":"2016","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27155398","citation_count":13,"is_preprint":false},{"pmid":"24362677","id":"PMC_24362677","title":"Spatiotemporal changes in NFATc4 expression of retinal ganglion cells after light-induced damage.","date":"2013","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/24362677","citation_count":13,"is_preprint":false},{"pmid":"32488182","id":"PMC_32488182","title":"Extracellular vesicles produced by NFAT3-expressing cells hinder tumor growth and metastatic dissemination.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32488182","citation_count":13,"is_preprint":false},{"pmid":"32805187","id":"PMC_32805187","title":"NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.","date":"2020","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/32805187","citation_count":13,"is_preprint":false},{"pmid":"28992110","id":"PMC_28992110","title":"NFAT3/c4-mediated excitotoxicity in hippocampal apoptosis during radiation-induced brain injury.","date":"2017","source":"Journal of radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/28992110","citation_count":12,"is_preprint":false},{"pmid":"28760926","id":"PMC_28760926","title":"Distinct roles of NFATc1 and NFATc4 in human primary myoblast differentiation and in the maintenance of reserve cells.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28760926","citation_count":12,"is_preprint":false},{"pmid":"31789412","id":"PMC_31789412","title":"Inhibition of calcineurin/NFATc4 signaling attenuates ventilator‑induced lung injury.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31789412","citation_count":11,"is_preprint":false},{"pmid":"25422138","id":"PMC_25422138","title":"Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.","date":"2014","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25422138","citation_count":11,"is_preprint":false},{"pmid":"24905014","id":"PMC_24905014","title":"NFAT1 and NFAT3 cooperate with HDAC4 during regulation of alternative splicing of PMCA isoforms in PC12 cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24905014","citation_count":10,"is_preprint":false},{"pmid":"29288061","id":"PMC_29288061","title":"The effect of brain-derived neurotrophic factor on radiation-induced neuron architecture impairment is associated with the NFATc4/3 pathway.","date":"2017","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/29288061","citation_count":10,"is_preprint":false},{"pmid":"25514788","id":"PMC_25514788","title":"Novel role for NFAT3 in ERK-mediated regulation of CXCR4.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25514788","citation_count":9,"is_preprint":false},{"pmid":"17194453","id":"PMC_17194453","title":"Tissue type-specific modulation of ER transcriptional activity by NFAT3.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17194453","citation_count":9,"is_preprint":false},{"pmid":"28849081","id":"PMC_28849081","title":"Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28849081","citation_count":9,"is_preprint":false},{"pmid":"25758355","id":"PMC_25758355","title":"Na(+)/H (+) exchanger isoform 1 induced osteopontin expression in cardiomyocytes involves NFAT3/Gata4.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25758355","citation_count":9,"is_preprint":false},{"pmid":"28577190","id":"PMC_28577190","title":"17β-Estradiol and/or estrogen receptor alpha blocks isoproterenol-induced calcium accumulation and hypertrophy via GSK3β/PP2A/NFAT3/ANP pathway.","date":"2017","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28577190","citation_count":8,"is_preprint":false},{"pmid":"29637744","id":"PMC_29637744","title":"The group VIA calcium-independent phospholipase A2 and NFATc4 pathway mediates IL-1β-induced expression of chemokines CCL2 and CXCL10 in rat fibroblasts.","date":"2018","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29637744","citation_count":8,"is_preprint":false},{"pmid":"38639863","id":"PMC_38639863","title":"NFATc4 Knockout Promotes Neuroprotection and Retinal Ganglion Cell Regeneration After Optic Nerve Injury.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/38639863","citation_count":7,"is_preprint":false},{"pmid":"21472269","id":"PMC_21472269","title":"Adrenergic receptor blockade-induced regression of pressure-overload cardiac hypertrophy is associated with inhibition of the calcineurin/NFAT3/GATA4 pathway.","date":"2010","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21472269","citation_count":7,"is_preprint":false},{"pmid":"29670896","id":"PMC_29670896","title":"Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/29670896","citation_count":7,"is_preprint":false},{"pmid":"35332122","id":"PMC_35332122","title":"CAMTA1-PPP3CA-NFATc4 multi-protein complex mediates the resistance of colorectal cancer to oxaliplatin.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35332122","citation_count":6,"is_preprint":false},{"pmid":"33149757","id":"PMC_33149757","title":"Cardiac CaMKIIδ and Wenxin Keli Prevents Ang II-Induced Cardiomyocyte Hypertrophy by Modulating CnA-NFATc4 and Inflammatory Signaling Pathways in H9c2 Cells.","date":"2020","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/33149757","citation_count":6,"is_preprint":false},{"pmid":"29926655","id":"PMC_29926655","title":"[Effects of hydrogen sulfide (H2S) on cardiac hypertrophy and miRNA-133a-mediated Ca2+/calcineurin/NFATc4 signal pathway in rats].","date":"2018","source":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29926655","citation_count":6,"is_preprint":false},{"pmid":"21792994","id":"PMC_21792994","title":"Capillary electrophoretic mobility shift assay for binding of DNA with NFAT3, a transcription factor from H9c2 cardiac myoblast cells.","date":"2011","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/21792994","citation_count":6,"is_preprint":false},{"pmid":"37753338","id":"PMC_37753338","title":"How does NFAT3 regulate the occurrence of cardiac hypertrophy?","date":"2023","source":"International journal of cardiology. Heart & vasculature","url":"https://pubmed.ncbi.nlm.nih.gov/37753338","citation_count":5,"is_preprint":false},{"pmid":"40843009","id":"PMC_40843009","title":"Ginsenoside Rb1 ameliorates post-doxorubicin treatment myocardial hypertrophy via CaN/NFATc4/GATA4.","date":"2025","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/40843009","citation_count":5,"is_preprint":false},{"pmid":"31486013","id":"PMC_31486013","title":"Involvement of calcineurin/NFATc4 pathway in a single-prolonged stress-based rat model of post-traumatic stress disorder.","date":"2019","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/31486013","citation_count":5,"is_preprint":false},{"pmid":"16645724","id":"PMC_16645724","title":"Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells.","date":"2006","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16645724","citation_count":4,"is_preprint":false},{"pmid":"16718377","id":"PMC_16718377","title":"NFAT3 is required for EGF-induced COX-2 transcription, but neither iNOS transcription nor cell transformation in Cl 41 cells.","date":"2006","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16718377","citation_count":4,"is_preprint":false},{"pmid":"23390317","id":"PMC_23390317","title":"p85α mediates NFAT3-dependent VEGF induction in the cellular UVB response.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23390317","citation_count":3,"is_preprint":false},{"pmid":"32982770","id":"PMC_32982770","title":"Inhibition of the NFATc4/ERK/AKT Pathway and Improvement of Thiol-Specific Oxidative Stress by Dronedarone Possibly Secondary to the Reduction of Blood Pressure in an Animal Model of Ventricular Hypertrophy.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32982770","citation_count":3,"is_preprint":false},{"pmid":"21081043","id":"PMC_21081043","title":"[Expression and significance of COX-2 and its transcription factors NFAT3 and c-Jun in non-small cell lung cancer].","date":"2010","source":"Zhongguo fei ai za zhi = Chinese journal of lung cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21081043","citation_count":3,"is_preprint":false},{"pmid":"39077755","id":"PMC_39077755","title":"NFAT3-FasL axis synchronously regulates apoptosis and necroptosis in murine cochlear outer hair cells after noise trauma.","date":"2024","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39077755","citation_count":2,"is_preprint":false},{"pmid":"40495950","id":"PMC_40495950","title":"Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism.","date":"2025","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/40495950","citation_count":2,"is_preprint":false},{"pmid":"37006873","id":"PMC_37006873","title":"4'‑O‑methylbavachalcone inhibits succinate induced cardiomyocyte hypertrophy via the NFATc4 pathway.","date":"2023","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37006873","citation_count":2,"is_preprint":false},{"pmid":"14990015","id":"PMC_14990015","title":"[CaN-NFAT3 signal pathway: a crucial hinge relates Ca2+ signal with cardiomyocyte hypertrophy].","date":"2004","source":"Zhonghua nei ke za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/14990015","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53817,"output_tokens":12144,"usd":0.171805,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23627,"output_tokens":8662,"usd":0.167343,"stage2_stop_reason":"end_turn"},"total_usd":0.339148,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"NFATc4 (NF-ATc4/NF-AT3) in hippocampal neurons translocates from cytoplasm to nucleus and activates NF-AT-dependent transcription in response to electrical activity or potassium depolarization. This calcineurin-mediated nuclear translocation is critically dependent on calcium entry through L-type voltage-gated calcium channels. GSK-3 phosphorylates NFATc4, promoting its nuclear export and antagonizing NFATc4-dependent transcription.\",\n      \"method\": \"Neuronal activity/K+ depolarization assays, pharmacological inhibition of calcineurin and L-type Ca2+ channels, GSK-3 phosphorylation assays, reporter gene assays, nuclear translocation imaging\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (pharmacology, imaging, reporter assays, kinase assays) in a highly cited single study; findings replicated by multiple subsequent labs\",\n      \"pmids\": [\"10537109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NFATc4 is phosphorylated by p38 MAP kinase at multiple residues including Ser168 and Ser170 within the NFAT homology domain. Replacement of Ser168,170 with Ala promotes nuclear localization of NFATc4 and increases NFAT-mediated transcription activity. NFATc4 is not phosphorylated by JNK. Constitutively nuclear NFATc4 (Ala168,170 mutant) promotes adipocyte differentiation via upregulation of PPARγ2, which is identified as a transcriptional target of NFAT.\",\n      \"method\": \"In vitro phosphorylation assays, site-directed mutagenesis, reporter assays, stable cell line expression, adipocyte differentiation assays, promoter analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, functional readout in cells, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"11997522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"NFATc4 contains two transactivation domains at the NH2 and COOH termini, each interacting with distinct regions of the coactivator CBP (KIX and CH3 domains respectively). Both transactivation domains are required for CBP-mediated potentiation of NFATc4 transcription; removal of either domain abolishes CBP potentiation.\",\n      \"method\": \"Co-immunoprecipitation, deletion mutagenesis, reporter assays, in vitro binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple deletion mutants with functional validation, reciprocal binding assays, single lab\",\n      \"pmids\": [\"11514544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In cardiac myocytes, Ras (but not Rac1, RhoA, or Cdc42) stimulates NFAT3 nuclear translocation and transcriptional activity via a calcineurin-dependent mechanism involving the MEK1/c-Raf/ERK2 pathway. Dominant-negative Ras blocks phenylephrine-stimulated NFAT3 activation and calcineurin activity. Cyclosporin A blocks V12ras-stimulated NFAT transcription, placing Ras upstream of calcineurin.\",\n      \"method\": \"Expression of constitutively active and dominant-negative Ras/GTPase mutants, reporter assays, NFAT3 nuclear localization imaging, calcineurin activity assays, pharmacological inhibitors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis established by multiple genetic tools (dominant-negative, constitutively active), multiple readouts, single lab\",\n      \"pmids\": [\"11044444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In cardiomyocytes stimulated by electrical pacing, calcineurin-mediated dephosphorylation of NFAT3 allows its translocation to the nucleus where it directly participates in activation of the Adss1 gene. Mutational analysis of the Adss1 5'-flanking region shows an NFAT binding site is essential for this activation.\",\n      \"method\": \"Electrical pacing of neonatal cardiomyocytes, calcineurin dephosphorylation assay, nuclear translocation assay, promoter mutational analysis, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional promoter mutagenesis and translocation assay, single lab\",\n      \"pmids\": [\"10636885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Genetic disruption of NFATc4 does not impair cardiac hypertrophic growth; in contrast, NFATc3 knockout significantly reduces calcineurin transgene-induced and pressure overload-induced cardiac hypertrophy. This genetic evidence shows NFATc4 is dispensable for calcineurin-mediated cardiac hypertrophy while NFATc3 is required.\",\n      \"method\": \"Targeted gene disruption (knockout mice), cardiac hypertrophy models (calcineurin transgene, pressure overload, angiotensin II), morphometric analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with multiple hypertrophic stimuli, replicated across timepoints\",\n      \"pmids\": [\"12370307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NFATc3 and NFATc4 are required for cardiac development; double knockout mice show embryonic lethality with thin ventricles, reduced cardiomyocyte proliferation, and defective mitochondrial function including reduced complex II and IV respiratory chain activity. Cardiac-specific expression of constitutively active NFATc4 in double-knockout embryos rescues ventricular myocyte proliferation, mitochondrial ultrastructure, and complex II enzyme activity, demonstrating NFATc4 is sufficient to support these functions.\",\n      \"method\": \"Double knockout mice, cardiac-specific rescue with constitutively active NFATc4 transgene, electron microscopy, enzymatic activity assays, histology\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — definitive genetic rescue experiment with biochemical validation of mitochondrial function\",\n      \"pmids\": [\"12750314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In hippocampal neurons, NFATc4 (NFAT3) accumulates in the nucleus under survival conditions (serum and high K+) and is exported under pro-apoptotic conditions. GSK3 inhibition by Li+ blocks NFATc4 nuclear export and promotes survival. RNA interference knockdown of NFAT3 induces apoptosis even under survival conditions, while constitutively active NFAT protects against apoptosis, demonstrating a pro-survival transcriptional function for NFAT3 in cerebellar granule neurons.\",\n      \"method\": \"Primary neuron culture, nuclear localization imaging, RNAi knockdown, Li+ pharmacology, apoptosis assays, constitutively active NFAT expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi loss-of-function and gain-of-function with defined apoptosis readout, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"15537643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NFATc4 (NFAT3) interacts with both ERα and ERβ in vitro and in mammalian cells in a ligand-independent manner, binding specifically to the ERβ activation function-1 domain. Overexpression of NFAT3 enhances ERα and ERβ transcriptional activities and upregulates downstream estrogen-responsive genes (pS2, cathepsin D). NFAT3 increases ERα binding to estrogen-responsive elements and is recruited to estrogen-responsive promoters.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, ChIP, reporter assays, siRNA knockdown, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal binding assays (yeast 2-hybrid + co-IP + pulldown) plus ChIP and functional reporter, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"16219765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RSK (p90 ribosomal S6 kinase) is recruited to the NFATc4-DNA transcription complex upon activation, demonstrated by DNA affinity isolation coupled with in-gel kinase assays. Bound RSK phosphorylates NFATc4 at Ser676, potentiating its DNA binding by increasing NFAT-DNA association. ERK MAP kinase interacts with NFATc4 at a distinct region from RSK.\",\n      \"method\": \"DNA affinity isolation, in-gel kinase assays, site-directed mutagenesis, phosphorylation assays, EMSA\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, DNA affinity isolation, functional readout, single lab with multiple methods\",\n      \"pmids\": [\"15657420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RSK2 directly interacts with NFATc4 (binding its NLS1, Ser/Pro repeat, and polyproline domains), phosphorylates NFATc4 in vitro (Km=3.559 μM), and induces nuclear localization of NFATc4 upon A23187 stimulation. RSK2-mediated activation of NFATc4 enhances its target gene promoter activity and promotes C2C12 myoblast differentiation into multinucleated myotubes. siRNA against RSK2, ERK1/2, or NFATc4 each inhibits myotube differentiation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, nuclear localization imaging, reporter assays, C2C12 differentiation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with Km determination, direct binding demonstrated, functional rescue/knockdown, single lab\",\n      \"pmids\": [\"17213202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"mTOR phosphorylates Ser168,170 of endogenous NFATc4 (gate-keeping residues controlling subcellular distribution), acting as a basal kinase to maintain NFATc4 in the cytosol. ERK5 MAP kinase also mediates rephosphorylation of Ser168,170 for nuclear export, and phosphorylation by ERK5 primes subsequent phosphorylation by CK1α. Ablation of ERK5 in Erk5-/- cells shows defects in NFATc4 rephosphorylation and nucleocytoplasmic shuttling.\",\n      \"method\": \"Phospho-specific monoclonal antibody, kinetic phosphorylation analyses, Erk5 knockout cells, pharmacological inhibition, mutagenesis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — phospho-specific antibody, genetic knockout validation, multiple kinase identification, single lab\",\n      \"pmids\": [\"18347059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NFATc4 protein stability and transcriptional activity are regulated by ubiquitination via Lys48-linked polyubiquitin chains, leading to decreased protein levels. GSK3β activation enhances NFATc4 ubiquitination and decreases its transactivation, while GSK3β inhibition has opposite effects. Ubiquitination and GSK3β-induced phosphorylation together repress NFATc4-dependent cardiac-specific gene expression.\",\n      \"method\": \"Ubiquitination assays, Western blot, GSK3β activation/inhibition, reporter assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional ubiquitination assay with pharmacological GSK3β manipulation, single lab, single paper\",\n      \"pmids\": [\"19026640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NFATc4 deafferentation-induced nuclear translocation and activation in AVCN neurons during a critical period is abolished by the calcineurin inhibitor FK506 and the NFAT-specific inhibitor 11R-VIVIT. NFATc4 activation mediates expression of FasL in cochlear nucleus, and NFAT inhibition attenuates deafferentation-induced apoptosis of AVCN neurons.\",\n      \"method\": \"In vivo cochlea removal, calcineurin inhibitor treatment, NFAT-specific peptide inhibitor (11R-VIVIT), immunostaining, apoptosis assays, FasL expression analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with specific inhibitors, mechanistic link to FasL, single lab\",\n      \"pmids\": [\"18354019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NFATc4 (NFAT-3) directly occupies the GAP-43 promoter and acts as a transcriptional repressor of GAP-43 in neurons. Overexpression of NFAT-3 represses GAP-43 activation mediated by neurotrophin signaling. Endogenous NFAT-3 occupies the GAP-43 promoter in PC-12 cells, cultured neurons, and mouse brain as shown by ChIP. NFAT-3 is required to repress physiological GAP-43 expression in specific developmental windows in the mouse brain.\",\n      \"method\": \"ChIP assay, overexpression, reporter assays, cortical neuron culture, in vivo brain analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP confirms direct promoter occupancy in vitro and in vivo, functional gain-of-function, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"19443652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NFATc4 (NFAT isoform c4) activation by NMDAR stimulation in cortical neurons promotes antiapoptotic transcription, in part by regulating BDNF promoter IV transcription. NFATc4 knockdown reduces BDNF expression and induces cortical neuron apoptosis, while BDNF rescues from NFATc4 inhibition-induced apoptosis, establishing an NMDAR-NFATc4-BDNF pro-survival pathway.\",\n      \"method\": \"RNAi knockdown of NFATc4, NMDAR pharmacology, reporter assays (BDNF promoter IV), BDNF rescue experiment, apoptosis assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown with specific BDNF rescue, reporter assay, pathway epistasis established, single lab\",\n      \"pmids\": [\"19955386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Lipin 1 represses NFATc4 transcriptional activity through direct protein-protein interaction. Both catalytically active and inactive lipin 1 suppress NFATc4 transcriptional activity, with suppression potentially involving recruitment of histone deacetylases to target promoters. Lipin 1 is present at the promoters of NFATc4 transcriptional targets (TNFα, resistin, FABP4, PPARγ) in vivo.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, ChIP assay, lipin-1 knockout mice, siRNA knockdown in 3T3-L1 adipocytes\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein interaction confirmed by Co-IP, ChIP establishes promoter occupancy, loss-of-function in vivo and in vitro, single lab\",\n      \"pmids\": [\"20385772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NFAT3 inhibits LCN2 (Lipocalin 2) gene expression and thereby reduces migration of ERα+ breast cancer cells. NFAT3 cooperates with ERα to inhibit migration but inhibits invasion independently. NFAT3 downregulation results in actin reorganization associated with increased migration and invasion.\",\n      \"method\": \"siRNA knockdown, invasion/migration assays, gene expression analysis, actin staining\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional loss-of-function with specific cellular phenotype and target gene identified, single lab, limited mechanistic depth\",\n      \"pmids\": [\"20101218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"FoxP1 physically interacts with Nfat3 (NFATc4) in cardiomyocytes; calcineurin activation induces FoxP1-Nfat3 complex formation visualized by bimolecular fluorescence complementation (BiFC). Amino acid substitutions at the predicted interaction interface inhibit complex formation. FoxP1 represses hypertrophy-associated genes (Myh7, Rcan1, Cx43, Anf, Bnp) and counteracts their activation by constitutively nuclear Nfat3. FoxP1 and Nfat3 co-occupy promoter regions of hypertrophy-associated genes in neonatal and adult heart tissue by ChIP.\",\n      \"method\": \"BiFC, co-immunoprecipitation, mutagenesis of interaction interface, reporter assays, ChIP, cardiomyocyte hypertrophy assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct interaction visualized by BiFC, ChIP in native tissue, interface mutagenesis, functional consequence established, single lab\",\n      \"pmids\": [\"21606195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NFATc4 calcineurin-dependent activity is required selectively for survival of adult-born neurons in response to BDNF signaling in the mouse dentate gyrus. In NFATc4-/- mice, cyclosporin A injection and BDNF scavenger (TrkB-Fc) do not reduce adult-born neuron survival, whereas they do in wild-type mice. Absence of NFATc4 leads to selective defects in LTP and hippocampal-dependent spatial memory encoding.\",\n      \"method\": \"NFATc4 knockout mice, cyclosporin A injection, stereotaxic TrkB-Fc delivery, BrdU labeling/survival assays, LTP recording, spatial memory testing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic knockout with pharmacological epistasis, mechanistic link to BDNF signaling, multiple behavioral and electrophysiological readouts, single lab\",\n      \"pmids\": [\"22586092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NFATc4 undergoes nuclear translocation only after prolonged (1-3 h) depolarization in neurons, in contrast to NFATc3 which translocates rapidly (~20 min). The serine-proline repeat region of NFATc4 is critical for determining the magnitude of NFATc4 nuclear localization. Knockdown of GSK3β significantly increases depolarization-induced NFATc4 nuclear localization. Inhibition of p38 or mTOR has no significant effect on NFATc4 nuclear import in neurons.\",\n      \"method\": \"NFATc3/NFATc4 chimera analysis, siRNA knockdown of GSK3β/p38/mTOR, live-cell imaging of nuclear translocation, phosphorylation assays in hippocampal and DRG neurons\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — chimeric protein domain mapping, genetic knockdown epistasis, multiple kinases tested, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"22977251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NFAT3 (NFATc4) directly regulates miR-140 transcription by binding to the regulatory sequence of miR-140 (rsmiR-140). NFAT3 activation increases rsmiR-140 activity, and mutagenesis of NFAT binding sites in rsmiR-140 abolishes this activation. TGF-β interferes with NFAT3 translocation and subsequently decreases miR-140 expression. NFAT3 and SMAD3 directly regulate miR-140 independently of WWP2.\",\n      \"method\": \"siRNA silencing, luciferase reporter assays with mutagenesis, ChIP assay, immunocytochemistry\",\n      \"journal\": \"Arthritis research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct binding, mutagenesis validates specific sites, multiple methods, single lab\",\n      \"pmids\": [\"24257415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NFATc4 is a transcriptional regulator of GABAA receptor subunits (GABRA2 and GABRA4) in hippocampal progenitor cells, regulating their expression via binding to specific promoter responsive elements as confirmed by ChIP and luciferase assays. GABAA receptor signaling modulates hippocampal neurogenesis through NFATc4 activity via calcineurin/NFATc4 axis.\",\n      \"method\": \"Genome-wide high-throughput study, ChIP assay, luciferase assays, calcineurin inhibitor treatment, NFATc4 knockout mice, neurogenesis quantification, behavioral assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP confirms direct promoter binding, knockout mouse validation, multiple functional readouts, single lab\",\n      \"pmids\": [\"24948817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NFAT3 directly binds to specific DNA sequences within the BACE1 promoter (confirmed by ChIP), increasing BACE1 promoter activity and transcription. Overexpression of NFAT3 increases BACE1 and Aβ production; disruption of NFAT3 decreases BACE1 gene transcription and protein expression.\",\n      \"method\": \"ChIP assay, reporter assays, overexpression, siRNA knockdown, Aβ measurement, transgenic APP/PS1 mice analysis\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct promoter binding, gain- and loss-of-function validated, single lab\",\n      \"pmids\": [\"25663301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CDK3 (cyclin-dependent kinase 3) directly interacts with NFATc4 (NFAT3) and phosphorylates it at serine 259 (Ser259), enhancing its transactivation and transcriptional activity. The Ser259 phosphorylation is critical for EGF-stimulated cell transformation; mutation of NFAT3 at Ser259 reduces colony formation and xenograft tumor growth.\",\n      \"method\": \"Mammalian two-hybrid assay, in vitro kinase assay, site-directed mutagenesis (S259A), reporter assays, soft-agar colony formation, xenograft mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with site-specific mutagenesis, direct interaction assay, functional phenotype in vitro and in vivo, single lab\",\n      \"pmids\": [\"27893713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NFATc4 interacts with myocardin to synergistically activate expression of the LTCC α1C (L-type Ca2+ channel α1C subunit) in cardiomyocytes. NFATc4 activates myocardin expression by binding to its promoter (confirmed by ChIP). Co-IP demonstrates direct NFATc4-myocardin interaction.\",\n      \"method\": \"Co-immunoprecipitation, ChIP assay, overexpression, siRNA knockdown, reporter assays, immunofluorescence, calcineurin inhibitor treatment\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP confirm interaction and promoter binding, single lab\",\n      \"pmids\": [\"27155398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Neuritin elevates intracellular Ca2+ and increases Kv4.2 expression via the Ca2+/calcineurin/NFATc4 axis in cerebellar granule neurons. NFATc4 is recruited to the Kv4.2 gene promoter (confirmed by ChIP and luciferase reporter). Neuritin-induced nuclear accumulation of NFATc4 and consequent Kv4.2 expression/neuronal excitability changes are abrogated in Nfatc4-/- but not Nfatc2-/- mice.\",\n      \"method\": \"Nfatc4 knockout mice, calcineurin inhibitor, ChIP assay, luciferase reporter, Ca2+ imaging, AAV-mediated overexpression, patch-clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — knockout mouse specificity, ChIP confirms direct promoter binding, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"27307045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFAT3 expression in T cells is regulated by TBX5; TBX5 binds to the NFAT3 promoter and its mutation diminishes NFAT3 promoter activity. NFAT3 in T cells suppresses IL-2 expression, while NFAT1 enhances it. The region of NFAT3 responsible for IL-2 promoter activity inhibition maps to the N-terminal transactivation domain, Ca2+-regulatory domain, and DNA-binding domain (identified by NFAT1/NFAT3 chimeric molecules).\",\n      \"method\": \"RNAi knockdown, reporter assays, NFAT1/NFAT3 chimeric molecules, promoter mutagenesis, TBX5 overexpression in T cells, chromatin accessibility analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chimeric domain mapping, mutagenesis, functional gain/loss-of-function, single lab\",\n      \"pmids\": [\"29180489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BDNF regulates neurodevelopmental timing via sequestration of NFATc4 in Golgi (extranuclear compartment), preventing its transcriptional repressor activity. This leads to accelerated derepression of an NFI temporal occupancy gene program in cerebellar granule cells, including Bdnf itself, forming an autoregulatory loop.\",\n      \"method\": \"Subcellular fractionation/imaging of NFATc4-Golgi localization, NFI target gene expression analysis, BDNF treatment, cerebellar granule cell culture\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — novel subcellular localization finding with functional consequence, single lab, limited mechanistic detail in abstract\",\n      \"pmids\": [\"29467254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIRT6 suppresses NFATc4 expression and activation in cardiomyocyte hypertrophy. SIRT6 overexpression represses NFATc4 protein/mRNA, elevates its phosphorylation, prevents nuclear accumulation, and suppresses BNP transcription. The catalytically inactive SIRT6 mutant (H133Y) does not show these effects, indicating dependence on deacetylase activity. SIRT6 physically interacts with NFATc4, suggesting SIRT6-mediated deacetylation of NFATc4.\",\n      \"method\": \"Adenovirus overexpression, plasmid transfection, catalytic mutant (H133Y), Western blot, immunofluorescence, siRNA rescue, co-immunoprecipitation\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — catalytic mutant controls demonstrate enzyme-dependence, Co-IP shows interaction, multiple readouts, single lab\",\n      \"pmids\": [\"30670969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RCAN1.4 downregulation via DNMT1/DNMT3b-mediated promoter methylation in liver fibrosis leads to enhanced calcineurin/NFAT3 signaling and hepatic stellate cell activation. RCAN1.4 overexpression alleviates TGF-β1-induced liver fibrosis in a CaN/NFAT3 signaling-dependent manner.\",\n      \"method\": \"Bisulfite sequencing, ChIP assay (DNMT1/3b binding), rAAV8-RCAN1.4 overexpression in mice, siRNA knockdown, protein-protein interaction network analysis, liver fibrosis model\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms epigenetic regulation of upstream inhibitor, in vivo rescue experiment, mechanistic link to CaN/NFAT3, single lab\",\n      \"pmids\": [\"31285763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFATc4 translocates from cytoplasm to nucleus in hepatocytes in NASH. Activated NFATc4 directly binds PPARα in the nucleus and negatively regulates its transcriptional activity, impairing hepatic fatty acid oxidation and increasing lipid deposition. NFATc4 activation increases osteopontin (OPN) production/secretion from hepatocytes, promoting macrophage-mediated inflammation and stellate cell fibrosis via paracrine signaling.\",\n      \"method\": \"Gain- and loss-of-function (NFATc4 overexpression/knockdown in mice and cells), nuclear fractionation, co-immunoprecipitation (NFATc4-PPARα interaction), NASH mouse model\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein interaction (Co-IP), in vivo knockout/overexpression, mechanistic pathway established, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"32717288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFATC4 nuclear translocation is triggered by cisplatin treatment in ovarian cancer cells. NFATC4 activation induces G0 cell cycle arrest, decreased proliferation, and chemotherapy resistance. NFATC4 drives quiescence in part via downregulation of MYC. Inhibition of the NFATC4 pathway increases chemotherapy response.\",\n      \"method\": \"Nuclear translocation imaging, cell cycle analysis, proliferation assays, MYC expression analysis, gain- and loss-of-function, in vitro and in vivo xenograft models\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function/inhibition with multiple readouts including in vivo, MYC identified as downstream mediator, single lab\",\n      \"pmids\": [\"32182216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NULP1 directly interacts with the topologically associating domain of NFAT3 via its C-terminal region (confirmed by co-immunoprecipitation), suppressing NFAT3 transcriptional activity. NULP1 knockout exacerbates aortic banding-induced cardiac hypertrophy while NULP1 transgenic overexpression blunts it. The NFAT pathway is identified as the downstream mechanism by VIVIT peptide rescue.\",\n      \"method\": \"Co-immunoprecipitation, Nulp1 knockout and transgenic mice, aortic banding, VIVIT peptide treatment, NFAT pathway screening, immunostaining\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP confirms direct interaction, genetic in vivo models with pharmacological rescue, single lab\",\n      \"pmids\": [\"32805187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SIRT2-mediated deacetylation of NFATc4 inhibits its nuclear translocation and acetylation status in ethanol-exposed hepatocytes. NFATc4 overexpression impairs the negative regulation of RIPK3 and DAMPs release. SIRT2 knockdown abolishes the inhibitory effects of pterostilbene on NFATc4 nuclear translocation and acetylation, placing SIRT2 as an upstream regulator of NFATc4 acetylation.\",\n      \"method\": \"SIRT2 knockdown, NFATc4 overexpression, Western blot, immunofluorescence, acetylation status analysis, RIPK3/DAMP measurement\",\n      \"journal\": \"Toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — knockdown epistasis with functional readout, single lab, deacetylation inferred rather than directly demonstrated in vitro\",\n      \"pmids\": [\"34474091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFATc4 triggers hepatocyte senescence via repression of PPARγ. NFATc4 knockdown counteracts ethanol-induced hepatocyte senescence markers and protects against alcoholic liver injury. PPARγ deficiency abrogates the inhibitory effects of NFATc4 knockdown on hepatocyte senescence, oxidative stress, and steatosis, placing PPARγ downstream of NFATc4.\",\n      \"method\": \"siRNA knockdown, PPARγ knockdown epistasis, Western blot, immunofluorescence, senescence-associated β-galactosidase staining, in vivo mouse model\",\n      \"journal\": \"Toxicology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis through double knockdown, in vivo validation, single lab\",\n      \"pmids\": [\"34192554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PPP3CA (calcineurin catalytic subunit) promotes dephosphorylation of NFATc4 and suppresses its phosphorylation, facilitating its nuclear translocation. CAMTA1 and PPP3CA competitively bind NFATc4; CAMTA1 knockdown promotes NFATc4 dephosphorylation (and resistance to oxaliplatin) in a PPP3CA-dependent manner. NFATc4 knockdown reverses oxaliplatin resistance caused by CAMTA1 knockdown, establishing a CAMTA1-PPP3CA-NFATc4 complex in colorectal cancer chemoresistance.\",\n      \"method\": \"Co-immunoprecipitation, competitive binding assay, siRNA knockdown epistasis, Western blot, xenograft mouse model\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — competitive Co-IP, triple epistasis knockdown, in vivo validation, single lab\",\n      \"pmids\": [\"35332122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Calcineurin (Cn) dephosphorylates NFATC4 (identified by phosphoproteomics) to regulate aldosterone synthase (CYP11B2) expression and aldosterone production in adrenal zona glomerulosa. ZG-specific deletion of calcineurin subunit CnB1 diminishes Cyp11b2 expression and disrupts K+-mediated aldosterone synthesis. Deletion of NFATC4 impairs K+-dependent CYP11B2 stimulation, while constitutively active NFATC4 increases CYP11B2 expression. ChIP confirms NFATC4 directly regulates CYP11B2 promoter.\",\n      \"method\": \"Phosphoproteomics, ZG-specific CnB1 knockout, NFATC4 knockout, constitutively active NFATC4 expression, ChIP assay, calcineurin inhibitor (tacrolimus) in cell line and ex vivo adrenal tissue\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — phosphoproteomics identifies substrate, multiple genetic models (tissue-specific KO, global KO, constitutively active), ChIP confirms direct target regulation, replicated in human cells and ex vivo tissue\",\n      \"pmids\": [\"37310791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Mettl1 increases SRSF9 expression by inducing m7G modification of SRSF9 mRNA, which facilitates alternative splicing and stabilization of NFATc4, thereby promoting cardiac hypertrophy. SRSF9 knockdown protects against TAC- or Mettl1-induced cardiac hypertrophy.\",\n      \"method\": \"Mettl1 knockout/cardiac-specific overexpression in mice, m7G modification assay, SRSF9 knockdown, alternative splicing analysis, TAC and Ang II models\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic chain established (Mettl1→m7G-SRSF9→NFATc4 splicing), in vivo models, single lab\",\n      \"pmids\": [\"38810124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NFATc4 knockout (but not NFATc3 knockout) increases RGC survival, improves retinal function, and delays axonal degeneration after optic nerve crush. NFATc4 is transiently upregulated and localizes to the ganglion cell layer after injury. Lentiviral re-delivery of NFATc4 to NFATc4-/- retinas reverses the pro-survival effect. NFATc4 knockout suppresses pro-apoptotic signaling (decreased cleaved caspase-3).\",\n      \"method\": \"NFATc4-/- and NFATc3-/- mice, optic nerve crush, lentiviral NFATc4 delivery rescue, microarray screening, immunostaining, retinal function testing\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific knockout with genetic rescue, microarray mechanism screen, isoform specificity confirmed by NFATc3 KO comparison, single lab\",\n      \"pmids\": [\"38639863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NFATc4 mediates expression of TNF and downstream hair cell apoptosis in the cochlea after ototoxic drug challenge. In Nfatc4-/- mice, hair cells show lower sensitivity to ototoxic damage and noise exposure, and the TNF-mediated apoptosis pathway is attenuated. NFATc4 is activated (nuclear translocation) in cochlear hair cells upon ototoxic challenge.\",\n      \"method\": \"Nfatc4-/- mice, ototoxic drug treatment, noise exposure, TNF and apoptosis pathway analysis, immunostaining\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse with defined molecular pathway (NFATc4→TNF→apoptosis), single lab\",\n      \"pmids\": [\"31379853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IL-18 suppresses adiponectin transcription via ERK1/2-dependent NFATc4 phosphorylation at Ser676 and NFATc4 nuclear translocation and in vivo DNA binding to the adiponectin promoter. IL-18 deletion or mutation of the NFATc4 core DNA-binding site in the adiponectin promoter-reporter reverses IL-18-mediated suppression. Inhibition of ERK1/2 attenuates NFATc4 Ser676 phosphorylation.\",\n      \"method\": \"Reporter assays with promoter mutation, ChIP (in vivo DNA binding), ERK inhibitors/siRNA, NFATc4 siRNA knockdown, nuclear translocation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct promoter binding confirmed by ChIP, mutagenesis of binding site, ERK1/2 epistasis, multiple methods, single lab\",\n      \"pmids\": [\"18086672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NFATc4 forms a ternary transcriptional complex with Nishéd and co-activator p300 at an intronic regulatory element (IRE) of the MLC-2v gene in cardiomyocytes. This complex formation is enhanced by angiotensin II stimulation. Losartan (AT1 receptor antagonist) abolishes agonist-dependent IRE-complex interaction and MLC-2v transcription.\",\n      \"method\": \"Gel mobility shift assay (EMSA), co-immunoprecipitation, reporter assays, pharmacological inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ternary complex demonstrated by EMSA and Co-IP, pharmacological epistasis, single lab\",\n      \"pmids\": [\"15272022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NFAT3 activity requires AP-1 co-binding for transcriptional activation; an NFAT3 promoter containing the NFAT core cis-element without an adjacent AP-1 binding site fails to show activation by H2O2 treatment. Dominant-negative c-Jun (TAM67) prevents H2O2 or ANG II from activating the NFAT3 promoter. ERK inhibition blocks AP-1 and NFAT3 activation.\",\n      \"method\": \"Promoter-luciferase reporter with AP-1 site mutations, dominant-negative c-Jun cotransfection, ERK pharmacological inhibition\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional promoter mutagenesis and dominant-negative epistasis, single lab\",\n      \"pmids\": [\"17108007\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NFATc4 (NFAT3) is a calcium/calcineurin-regulated transcription factor that, upon dephosphorylation by calcineurin, translocates from the cytoplasm to the nucleus to activate target gene transcription; its activity is controlled by multiple kinases that phosphorylate gate-keeping serine residues (GSK-3 at export, p38 MAPK/mTOR/ERK5 at Ser168/170, RSK/ERK at Ser676, CDK3 at Ser259) to promote nuclear export or modulate transcriptional activity, by ubiquitin-proteasome degradation, and by post-translational modifications including deacetylation by SIRT6 and SIRT2; it forms functional complexes with CBP (via two distinct transactivation domains), FoxP1, GATA-4, myocardin, PPARα, estrogen receptors, p300/Nishéd, and NULP1, and directly regulates a broad array of target genes (including BDNF, GAP-43, PPARγ2, Adss1, MLC-2v, LTCC α1C, FasL, CYP11B2, Kv4.2, BACE1, LCN2, adiponectin, and pro-inflammatory cytokines) in diverse tissues including heart, neurons, adipose, liver, cochlea, adrenal gland, and immune cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NFATc4 (NFAT3) is a calcium/calcineurin-regulated transcription factor that, upon dephosphorylation of gate-keeping serines, translocates from the cytoplasm to the nucleus to control programs of cell survival, differentiation, and stress adaptation across neurons, heart, liver, adipose, adrenal, and immune tissues [#0, #37]. Calcium entry — through L-type voltage-gated channels in neurons or in response to depolarization, growth-factor, and Gq/Ras signaling — activates calcineurin (PPP3CA), which dephosphorylates NFATc4 and drives nuclear import, an event placed downstream of Ras/MEK/ERK in cardiomyocytes [#0, #3, #37]. Nuclear residence is opposed by a layered kinase network: GSK-3 phosphorylates NFATc4 to promote nuclear export, mTOR and ERK5 maintain or restore phosphorylation of the gate-keeping Ser168/170 (ERK5 priming subsequent CK1\\u03b1 phosphorylation), and the serine-proline repeat region sets its characteristically slow, prolonged translocation kinetics relative to NFATc3 [#0, #11, #20]. By contrast, RSK/ERK phosphorylation at Ser676 and CDK3 phosphorylation at Ser259 potentiate DNA binding and transactivation, while p38 phosphorylation of Ser168/170 restrains nuclear localization [#1, #9, #10, #24]. NFATc4 acts through two transactivation domains that engage distinct CBP regions and partners with p300/Nish\\u00e9 to build transcription complexes, and its output is further tuned by competing repressors (FoxP1, lipin-1, NULP1) and by acetylation/deacetylation through SIRT6 and SIRT2 and Lys48 ubiquitin-proteasome turnover [#1, #2, #9, #24, #16, #18, #29, #33, #42, #34, #12]. Functionally it can both activate and repress targets: it drives pro-survival BDNF and GABAA-receptor subunit programs and Kv4.2 in neurons, regulates CYP11B2/aldosterone synthesis in adrenal zona glomerulosa, and synergizes with myocardin and supports mitochondrial maturation in heart, yet represses GAP-43 in neurons and antagonizes PPAR\\u03b1/PPAR\\u03b3 in hepatocytes [#15, #22, #26, #37, #25, #6, #14, #31, #35]. Genetically, NFATc4 is dispensable for calcineurin-induced cardiac hypertrophy but, redundantly with NFATc3, is required for embryonic cardiac development and mitochondrial respiratory function [#5, #6]. Across injury and disease contexts it functions as a stress-induced effector — driving FasL- and TNF-mediated apoptosis in cochlear and ototoxin-challenged neurons, RGC degeneration after optic nerve injury, OPN-driven hepatic inflammation in NASH, and MYC-suppression-linked quiescence and chemoresistance in ovarian and colorectal cancer [#13, #40, #39, #31, #32, #36].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the core activation logic of NFATc4 in excitable cells: how an extracellular electrical/calcium signal is converted into a nuclear transcriptional response.\",\n      \"evidence\": \"K+ depolarization with calcineurin/L-type Ca2+ channel pharmacology, GSK-3 kinase and reporter assays in hippocampal neurons\",\n      \"pmids\": [\"10537109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify endogenous target genes activated in neurons\", \"Mechanism of GSK-3-driven export not resolved at residue level\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined upstream signaling specificity in heart, showing Ras/MEK/ERK acts above calcineurin to drive NFAT3 activation and that NFAT3 directly activates a metabolic target.\",\n      \"evidence\": \"Constitutively active/dominant-negative Ras and GTPase mutants, calcineurin assays, and Adss1 promoter mutagenesis in cardiomyocytes\",\n      \"pmids\": [\"11044444\", \"10636885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ERK signaling intersects calcineurin biochemically was not defined\", \"Adss1 regulation was correlative beyond a single binding site\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapped the coactivator interface, showing NFATc4 uses two transactivation domains binding distinct CBP regions, defining how it recruits transcriptional machinery.\",\n      \"evidence\": \"Deletion mutagenesis, Co-IP, and in vitro binding with reporter assays\",\n      \"pmids\": [\"11514544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the dual interaction not resolved\", \"Context-dependence of CBP recruitment at native promoters untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified phosphorylation gate-keeping (p38 at Ser168/170) and provided in vivo genetic proof that NFATc4 is dispensable for cardiac hypertrophy, separating its function from the redundant paralog NFATc3.\",\n      \"evidence\": \"In vitro kinase assays with S168/170A mutagenesis and adipocyte differentiation; NFATc4 vs NFATc3 knockout mice in multiple hypertrophy models\",\n      \"pmids\": [\"11997522\", \"12370307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional redundancy with NFATc3 in heart not yet defined\", \"PPAR\\u03b32 regulation shown in cell lines only\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved the developmental requirement, showing NFATc3/c4 are jointly essential for cardiac morphogenesis and mitochondrial respiratory function, with NFATc4 alone sufficient to rescue.\",\n      \"evidence\": \"Double-knockout mice with cardiac-specific constitutively active NFATc4 rescue, EM and respiratory chain enzymology\",\n      \"pmids\": [\"12750314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mitochondrial/proliferative target genes not identified\", \"Mechanism of complex II/IV regulation unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Extended the coactivator model to native cardiac loci, showing NFATc4 forms a Nish\\u00e9d/p300 ternary complex at the MLC-2v enhancer under angiotensin II/AT1 signaling.\",\n      \"evidence\": \"EMSA, Co-IP, reporter assays with losartan in cardiomyocytes\",\n      \"pmids\": [\"15272022\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nish\\u00e9d identity/role only partially defined\", \"Direct vs bridged contacts within the ternary complex unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined two positive regulatory branches: RSK recruitment to the NFATc4-DNA complex (Ser676) enhancing DNA binding, and ligand-independent cooperation with estrogen receptors.\",\n      \"evidence\": \"DNA affinity isolation/in-gel kinase assays and EMSA; yeast two-hybrid, GST pulldown, Co-IP, and ChIP at estrogen-responsive promoters\",\n      \"pmids\": [\"15657420\", \"16219765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts of ER cooperation limited\", \"How RSK access to the DNA-bound complex is regulated unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected RSK2/ERK signaling to a differentiation program and to metabolic gene repression, showing NFATc4 drives myotube formation and mediates IL-18 suppression of adiponectin.\",\n      \"evidence\": \"In vitro kinase assays with Km, Co-IP, siRNA, C2C12 differentiation; ChIP and promoter mutagenesis with ERK epistasis on the adiponectin promoter\",\n      \"pmids\": [\"17213202\", \"18086672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct myogenic target genes not enumerated\", \"Ser676 phosphorylation as activator vs the export-promoting kinases not reconciled\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Built the multi-kinase shuttling and degradation control circuit, identifying mTOR as a basal cytosolic-retention kinase, ERK5/CK1\\u03b1 as a rephosphorylation/export module, AP-1 as an obligate co-binding partner, and Lys48 ubiquitination as a stability switch.\",\n      \"evidence\": \"Phospho-specific antibodies and Erk5-/- cells; promoter mutagenesis with dominant-negative c-Jun; ubiquitination assays with GSK3\\u03b2 manipulation\",\n      \"pmids\": [\"18347059\", \"17108007\", \"19026640\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating Lys48 ubiquitination not identified\", \"Ubiquitination finding rests on a single Medium-confidence study\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated tissue-specific apoptotic roles, showing NFATc4 drives FasL-dependent neuronal death in the cochlear nucleus after deafferentation during a critical period.\",\n      \"evidence\": \"In vivo cochlea removal with FK506 and 11R-VIVIT inhibitors, apoptosis and FasL assays\",\n      \"pmids\": [\"18354019\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct FasL promoter occupancy by NFATc4 not shown here\", \"Reconciliation with pro-survival neuronal roles unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved the dual activator/repressor nature in neurons, showing NFATc4 directly represses GAP-43 yet sustains pro-survival BDNF promoter IV transcription downstream of NMDAR.\",\n      \"evidence\": \"ChIP in cells and brain with overexpression for GAP-43; RNAi knockdown with BDNF rescue and promoter IV reporters\",\n      \"pmids\": [\"19443652\", \"19955386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What determines activator vs repressor mode at a given promoter is unknown\", \"Cofactors mediating GAP-43 repression not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified direct protein repressors and a cancer-relevant target, showing lipin-1 binds and represses NFATc4 (likely via HDAC recruitment) and NFAT3 suppresses LCN2 to restrain breast cancer cell motility.\",\n      \"evidence\": \"Co-IP, ChIP, lipin-1 knockout/siRNA in adipocytes; siRNA with migration/invasion and actin assays in ER\\u03b1+ breast cancer\",\n      \"pmids\": [\"20385772\", \"20101218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"HDAC identity in lipin-1 repression not confirmed\", \"LCN2 regulation mechanistically shallow (Medium confidence)\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established a direct cardiac antagonist, showing FoxP1 binds NFATc4 upon calcineurin activation and co-occupies hypertrophy gene promoters to oppose their activation.\",\n      \"evidence\": \"BiFC, Co-IP, interface mutagenesis, ChIP in native heart tissue, hypertrophy reporter assays\",\n      \"pmids\": [\"21606195\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FoxP1 recruits corepressors or blocks DNA binding not distinguished\", \"In vivo phenotype of the complex not tested by genetics\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined kinetic and physiological distinctness from NFATc3, showing NFATc4 translocates slowly (controlled by its Ser-Pro repeat and GSK3\\u03b2) and is specifically required for BDNF-dependent adult neurogenesis, LTP, and spatial memory.\",\n      \"evidence\": \"NFATc3/c4 chimeras and kinase knockdowns with live imaging; NFATc4 knockout mice with CsA/TrkB-Fc, BrdU survival, LTP, and behavior\",\n      \"pmids\": [\"22977251\", \"22586092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why p38/mTOR inhibition lacked effect on neuronal import vs other systems unexplained\", \"Direct neurogenesis target genes not identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended direct target repertoire to a microRNA and chondrocyte signaling, showing NFAT3 binds and activates the miR-140 regulatory sequence and is antagonized by TGF-\\u03b2.\",\n      \"evidence\": \"siRNA, luciferase with binding-site mutagenesis, ChIP, immunocytochemistry\",\n      \"pmids\": [\"24257415\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological role of NFAT3-miR-140 axis not established in vivo\", \"Interplay with SMAD3 only partially defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Added neurodevelopmental gene targets, showing NFATc4 directly regulates GABAA receptor subunits GABRA2/GABRA4 to couple GABA signaling to hippocampal neurogenesis.\",\n      \"evidence\": \"Genome-wide screen, ChIP, luciferase, calcineurin inhibition, NFATc4 knockout mice, behavior\",\n      \"pmids\": [\"24948817\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Activator vs repressor mode at these promoters not detailed\", \"Link between subunit expression and behavioral output indirect\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Implicated NFATc4 in Alzheimer-relevant transcription, showing it directly binds the BACE1 promoter to increase BACE1 and A\\u03b2 production.\",\n      \"evidence\": \"ChIP, reporter, overexpression/siRNA, A\\u03b2 measurement, APP/PS1 mice\",\n      \"pmids\": [\"25663301\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No causal genetic test of NFATc4 in AD models\", \"Single Medium-confidence study\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified an additional activating kinase and direct cardiac/neuronal targets: CDK3 phosphorylates Ser259 to drive transformation, NFATc4 synergizes with myocardin for LTCC \\u03b11C, and mediates neuritin-induced Kv4.2 expression.\",\n      \"evidence\": \"In vitro kinase/two-hybrid with S259A and xenografts; Co-IP and ChIP for myocardin/LTCC; NFATc4 vs NFATc2 knockout mice and ChIP for Kv4.2\",\n      \"pmids\": [\"27893713\", \"27155398\", \"27307045\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hierarchy among the multiple activating phosphorylation sites unresolved\", \"Myocardin study Medium confidence\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined an immune-suppressive role distinct from other NFAT family members, showing NFAT3 represses IL-2 (opposite to NFAT1) under TBX5 control.\",\n      \"evidence\": \"RNAi, NFAT1/NFAT3 chimeras, promoter mutagenesis, TBX5 overexpression in T cells\",\n      \"pmids\": [\"29180489\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of repression (cofactor recruitment) not defined\", \"In vivo immune phenotype untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed a non-canonical extranuclear regulatory mode, showing BDNF sequesters NFATc4 in the Golgi to relieve its repressor activity and time an NFI gene program.\",\n      \"evidence\": \"Subcellular fractionation/imaging and NFI target expression in cerebellar granule cells\",\n      \"pmids\": [\"29467254\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of Golgi sequestration unknown\", \"Limited mechanistic detail (Medium confidence)\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established acetylation control and disease roles, showing SIRT6 deacetylase activity suppresses NFATc4 in cardiac hypertrophy and NFATc4 drives TNF-mediated cochlear hair-cell apoptosis.\",\n      \"evidence\": \"Adenoviral SIRT6 with catalytic mutant H133Y and Co-IP; Nfatc4-/- mice with ototoxic/noise challenge and TNF/apoptosis analysis\",\n      \"pmids\": [\"30670969\", \"31379853\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct deacetylated lysine residues not mapped\", \"SIRT6 effect on protein level vs activity entangled\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed NFATc4 within an epigenetically controlled fibrotic axis, showing RCAN1.4 silencing de-represses calcineurin/NFAT3 to drive hepatic stellate cell activation.\",\n      \"evidence\": \"Bisulfite sequencing, ChIP of DNMTs, rAAV8-RCAN1.4 rescue in liver fibrosis model\",\n      \"pmids\": [\"31285763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct fibrotic target genes of NFAT3 not defined\", \"RCAN1.4 effect on NFAT3 inferred via calcineurin\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined hepatic metabolic and inflammatory mechanisms, showing nuclear NFATc4 binds and inhibits PPAR\\u03b1 to impair fatty acid oxidation and induces OPN to drive NASH inflammation/fibrosis, while in cancer it induces MYC-low quiescence and chemoresistance.\",\n      \"evidence\": \"Co-IP and in vivo gain/loss-of-function in NASH; nuclear translocation, cell-cycle, MYC analysis and xenografts in ovarian cancer\",\n      \"pmids\": [\"32717288\", \"32182216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether OPN is a direct NFATc4 target promoter untested\", \"Mechanism of MYC downregulation not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified an additional cardiac repressor, showing NULP1 directly binds NFAT3 and blunts pressure-overload hypertrophy through NFAT pathway suppression.\",\n      \"evidence\": \"Co-IP, Nulp1 knockout/transgenic mice, aortic banding, VIVIT peptide rescue\",\n      \"pmids\": [\"32805187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NULP1 blocks DNA binding or recruits corepressors not distinguished\", \"Target genes affected not enumerated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended acetylation regulation and hepatic injury mechanisms, showing SIRT2 deacetylation inhibits NFATc4 nuclear translocation and NFATc4 drives PPAR\\u03b3-dependent hepatocyte senescence in alcoholic liver injury.\",\n      \"evidence\": \"SIRT2 knockdown epistasis with acetylation/RIPK3 readouts; NFATc4/PPAR\\u03b3 double knockdown with senescence assays in vivo\",\n      \"pmids\": [\"34474091\", \"34192554\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct deacetylation of NFATc4 by SIRT2 inferred, not shown in vitro\", \"PPAR\\u03b3 repression mechanism (direct vs indirect) unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined a competitive scaffolding mechanism for activation, showing CAMTA1 and PPP3CA competitively bind NFATc4 to set its phosphorylation/activation and chemoresistance in colorectal cancer.\",\n      \"evidence\": \"Competitive Co-IP, triple siRNA epistasis, xenografts\",\n      \"pmids\": [\"35332122\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CAMTA1-NFATc4 contact vs bridged interaction unresolved\", \"Target genes mediating chemoresistance not identified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided definitive substrate-level and target-level proof in an endocrine context, identifying NFATC4 as a calcineurin substrate that directly drives CYP11B2 and K+-dependent aldosterone synthesis.\",\n      \"evidence\": \"Phosphoproteomics, ZG-specific CnB1 knockout, NFATC4 knockout and constitutively active expression, ChIP, ex vivo human/adrenal tissue\",\n      \"pmids\": [\"37310791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphosites dephosphorylated by calcineurin in adrenal not mapped\", \"Cofactors at the CYP11B2 promoter not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Added post-transcriptional control and reinforced isoform-specific injury roles, showing Mettl1/m7G-SRSF9 splicing stabilizes NFATc4 to promote hypertrophy and that NFATc4 (not NFATc3) drives retinal ganglion cell death after injury.\",\n      \"evidence\": \"Mettl1 mouse models with m7G and SRSF9 knockdown in TAC; NFATc4-/- vs NFATc3-/- mice with lentiviral rescue and microarray after optic nerve crush\",\n      \"pmids\": [\"38810124\", \"38639863\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NFATc4 splice isoforms regulated by SRSF9 not characterized\", \"RGC pro-apoptotic target genes only screened, not validated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"What determines whether activated NFATc4 acts as a transcriptional activator versus repressor at a given promoter, and how the many competing kinases, deacetylases, and protein partners are integrated in vivo within a single cell type, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model reconciling activating (Ser259/Ser676) vs export-promoting phosphorylation\", \"Genome-wide direct target maps largely absent across tissues\", \"Structural basis of partner-driven activator/repressor switching unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 14, 22, 23, 26, 37, 41]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 9, 14, 23, 26, 37, 41]},\n      {\"term_id\": \"GO:0140297\", \"supporting_discovery_ids\": []}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 7, 20, 31, 37]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 11, 20]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 14, 37, 41]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 11, 37]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [7, 13, 15, 39, 40]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 10, 22]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CBP\", \"FoxP1\", \"myocardin\", \"PPARA\", \"ESR1\", \"NULP1\", \"PPP3CA\", \"RPS6KA2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}